EurekaMag PDF full texts Chapter 46,252

Valkonen, K.H.; Ringner, M.; Ljungh, A.; Wadström, T. 1993: High-affinity binding of laminin by Helicobacter pylori: evidence for a lectin-like interaction. Fems Immunology and Medical Microbiology 7(1): 29-37

Ideo, H.; Seko, A.; Ohkura, T.; Matta, K.L.; Yamashita, K. 2002: High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside. Glycobiology 12(3): 199-208

Trust, T.J.; Kostrzynska, M.; Emödy, L.; Wadström, T. 1993: High-affinity binding of the basement membrane protein collagen type IV to the crystalline virulence surface protein array of Aeromonas salmonicida. Molecular Microbiology 7(4): 593-600

Johnson, D.G.; Coleman, A.; Powell, K.L.; MacLeod, M.C. 1997: High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts. Molecular Carcinogenesis 20(2): 216-223

Shi, Y.; Zou, M.; Parhar, R.S.; Farid, N.R. 1993: High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells. Thyroid: Official Journal of the American Thyroid Association 3(2): 129-133

Inoue, K.; Shimada, H.; Ueba, J.; Enomoto, S.; Tanaka-Saisaka, Y.; Kubota, T.; Koyama, M.; Morita, T. 1996: High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII. Biochemistry 35(43): 13826-13832

Happe, H.K.; Murrin, L.C. 1993: High-affinity choline transport sites: use of [3H]hemicholinium-3 as a quantitative marker. Journal of Neurochemistry 60(4): 1191-1201

Van Twuyver, E.; Mooijaart, R.J.; ten Berge, I.J.; van der Horst, A.R.; Wilmink, J.M.; Claas, F.H.; de Waal, L.P. 1994: High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion--the other side of the coin. Transplantation 57(8): 1246-1251

Homma, M.; Suzuki, H.; Kusuhara, H.; Naito, M.; Tsuruo, T.; Sugiyama, Y. 1999: High-affinity efflux transport system for glutathione conjugates on the luminal membrane of a mouse brain capillary endothelial cell line (MBEC4). Journal of Pharmacology and Experimental Therapeutics 288(1): 198-203

Yang, R.; Yang, X.L. 2000: High-affinity glutamate transporters. Sheng Li Ke Xue Jin Zhan 31(4): 293-298

Kuyper, L.F.; Baccanari, D.P.; Jones, M.L.; Hunter, R.N.; Tansik, R.L.; Joyner, S.S.; Boytos, C.M.; Rudolph, S.K.; Knick, V.; Wilson, H.R.; Caddell, J.M.; Friedman, H.S.; Comley, J.C.; Stables, J.N. 1996: High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. Journal of Medicinal Chemistry 39(4): 892-903

Kilpatrick, K.E.; Danger, D.P.; Hull-Ryde, E.A.; Dallas, W. 2000: High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 microg of DNA. Hybridoma 19(4): 297-302

Bogdanffy, M.S.; Manning, L.A.; Sarangapani, R. 1999: High-affinity nasal extraction of vinyl acetate vapor is carboxylesterase dependent. Inhalation Toxicology 11(10): 927-941

Koenderink, J.B.; Hermsen, H.P.; Swarts, H.G.; Willems, P.H.; De Pont, J.J. 2000: High-affinity ouabain binding by a chimeric gastric H+,K+-ATPase containing transmembrane hairpins M3-M4 and M5-M6 of the alpha 1-subunit of rat Na+,K+-ATPase. Proceedings of the National Academy of Sciences of the United States of America 97(21): 11209-11214

Jacobsen, E.J.; TenBrink, R.E.; Stelzer, L.S.; Belonga, K.L.; Carter, D.B.; Im, H.K.; Im, W.B.; Sethy, V.H.; Tang, A.H.; VonVoigtlander, P.F.; Petke, J.D. 1996: High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex. Journal of Medicinal Chemistry 39(1): 158-175

Wong, D.W.; Robertson, G.H. 1998: High-affinity peptide ligands for pancreatic alpha-amylase by phage display. Annals of the new York Academy of Sciences 864: 555-557

Rajeev, K.G.; Maier, M.A.; Lesnik, E.A.; Manoharan, M. 2002: High-affinity peptide nucleic acid oligomers containing tricyclic cytosine analogues. Organic Letters 4(25): 4395-4398

Breyer-Pfaff, U.; Nill, K. 2000: High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver. Biochemical Pharmacology 59(3): 249-260

Nakamura, H.; Huang, S.H.; Takakura, K. 1996: High-affinity taurine uptake and its regulation by protein kinase C in human glioma cells. Advances in Experimental Medicine and Biology 403: 377-384

Anonymous 1999: High-alert medications and patient safety. Sentinel event alert 1999(11): 1-3

Basnyat, B. 1999: High-altitude cerebral edema. JAMA 281(19): 1794; Author Reply 1795

Greene, H.M.; Wickler, S.J.; Anderson, T.P.; Cogger, E.A.; Lewis, C.C.; Wyle, A. 1999: High-altitude effects on respiratory gases, acid-base balance and pulmonary artery pressures in equids. Equine Veterinary Journal. Supplement 1999(30): 71-76

Basnyat, B. 2000: High-altitude emergency medicine. Lancet 356 Suppl: S1

Ogilvie, R.I. 2001: High-altitude illness. New England Journal of Medicine 345(17): 1279-1280; Author Reply 1280-1281

Finsterer, J. 1999: High-altitude illness induced by tooth root infection. Postgraduate Medical Journal 75(882): 227-228

McMahon, C.J.; Hicks, J.M.; Dreyer, W.J. 2001: High-altitude precipitation and exacerbation of protein-losing enteropathy after a Fontan operation. Cardiology in the Young 11(2): 225-228

Goetz, A.E.; Kuebler, W.M.; Peter, K. 1996: High-altitude pulmonary edema. New England Journal of Medicine 335(3): 206-207

de Clari, F.; von Albertini, M. 1996: High-altitude pulmonary edema. New England Journal of Medicine 335(3): 207

Voelkel, N.F. 2002: High-altitude pulmonary edema. New England Journal of Medicine 346(21): 1606-1607

Hultgren, H.N.; Honigman, B.; Theis, K.; Nicholas, D. 1996: High-altitude pulmonary edema at a ski resort. Western Journal of Medicine 164(3): 222-227

Gabry, A.é L.; Ledoux, X.; Mozziconacci, M.; Martin, C. 2003: High-altitude pulmonary edema at moderate altitude (< 2,400 m; 7,870 feet): a series of 52 patients. Chest 123(1): 49-53

Kobayashi, T. 1995: High-altitude pulmonary edema in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 33 Suppl: 1-6

Sartori, C.; Trueb, L.; Scherrer, U. 1997: High-altitude pulmonary edema. Mechanisms and management. Cardiologia 42(6): 559-567

Angerio, A.D.; Kot, P.A. 1996: High-altitude pulmonary edema: a clinical crisis. Critical Care Nursing Quarterly 19(3): 70-76

Arnett, F.C. 1998: High-altitude pulmonary edema: an immunogenetically mediated disease?. Circulation 97(12): 1111-1113

Scherrer, U.; Sartori, C.; Lepori, M.; Allemann, Y.; Duplain, H.; Trueb, L.; Nicod, P. 1999: High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport. Advances in Experimental Medicine and Biology 474: 93-107

Schoene, R.B. 1997: High-altitude pulmonary edema: more lessons from the master. Wilderness and Environmental Medicine 8(4): 202-203

Niazova, Z.A.; Batyraliev, T.A.; Aikimbaev, K.S.; Kudaiberdieva, G.Z.; Akgul, F.; Soodanbekova, Y.K.; Birand, A. 1996: High-altitude pulmonary hypertension: effects of captopril on pulmonary and systemic arterial pressures. Journal of Human Hypertension 10 Suppl. 3: S141-S142

Petculescu, G.; Wilen, L.A. 2001: High-amplitude thermoacoustic effects in a single pore. Journal of the Acoustical Society of America 109(3): 942-948

Mitsuishi, K.; Kawasaki, M.; Takeguchi, M.; Yasuda, H.; Furuya, K. 2001: High-angle annular dark-field STEM observation of Xe nanocrystals embedded in Al. Ultramicroscopy 88(1): 25-31

Liu, C.P.; Twesten, R.D.; Gibson, J.M. 2001: High-angle annular dark-field imaging of self-assembled Ge islands on Si(0 0 1). Ultramicroscopy 87(1-2): 79-88

Liu; Nowak; Jaeger; Vuchic; Merkle; Buchholz; Chang 1995: High-angle grain-boundary junctions in YBa2Cu3O7: Normal-state resistance and 1/f noise. Physical Review. B Condensed Matter 51(22): 16164-16167

Via; Bauer; Potemski; Maan; Mendez; Wang 1988: High-angular-momentum excitons in GaAs/Ga1-xAlxAs quantum wells. Physical Review. B Condensed Matter 38(14): 10154-10157

De Boer MP; Noordam; Muller 1993: High-angular-momentum states as population traps in multiphoton ionization. Physical Review. a Atomic Molecular and Optical Physics 47(1): R45-R48

Dutta, S.K.; Feldbaum, D.; Walz-Flannigan, A.; Guest, J.R.; Raithel, G. 2001: High-angular-momentum states in cold Rydberg gases. Physical Review Letters 86(18): 3993-3996

Xu; Cooke 1993: High-angular-momentum transfer during the autoionization of the 6p1/2nd J=3 states of barium. Physical Review. a Atomic Molecular and Optical Physics 48(3): 2054-2057

Sheppard, C.J. 2001: High-aperture beams. Journal of the Optical Society of America. A Optics Image Science and Vision 18(7): 1579-1587

Cronin; Torok; Varga; Cogswell 2000: High-aperture diffraction of a scalar, off-axis Gaussian beam. Journal of the Optical Society of America. a Optics Image Science and Vision 17(9): 1556-1564

Richardson; McKenty; Keck; Marshall; Roback; Verdon; McCrory; Soures; Lane 1986: High-aspect-ratio laser-fusion targets driven by 24-beam uv laser radiation. Physical Review Letters 56(19): 2048-2051

Matsuki, Y.; Suzuki, K.; Kawakami, M.; Ishizuka, T.; Kawaguchi, Y.; Hidaka, T.; Nakamura, H. 1996: High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns. Journal of Clinical Apheresis 11(1): 30-35

Alessi, N. 2002: High-bandwidth interactive telepsychiatry. Psychiatric Services 53(7): 901; Author Reply 902

Canada, T.A.; Xue, Z. 2002: High-basicity determination in mixed water-alcohol solutions by a dual optical sensor approach. Analytical Chemistry 74(23): 6073-6079

Ware, A.S.; Hirshman, S.P.; Spong, D.A.; Berry, L.A.; Deisher, A.J.; Fu, G.Y.; Lyon, J.F.; Sanchez, R. 2002: High-beta equilibria of drift-optimized compact stellarators. Physical Review Letters 89(12): 125003

Chan, B.; Anderson, G.M.; Thériault, M.E. 1998: High-billing general practitioners and family physicians in Ontario: how do they do it? An analysis of practice patterns of GP/FPs with annual billings over \$400,000. Cmaj: Canadian Medical Association Journal 158(6): 741-746

Cheng, T.-C.; Victoria-Feser, M.-P. 2002: High-breakdown estimation of multivariate mean and covariance with missing observations. British Journal of Mathematical and Statistical Psychology 55(Part 2): 317-335

Nisoli, M.; Priori, E.; Sansone, G.; Stagira, S.; Cerullo, G.; De Silvestri, S.; Altucci, C.; Bruzzese, R.; de Lisio, C.; Villoresi, P.; Poletto, L.; Pascolini, M.; Tondello, G. 2002: High-brightness high-order harmonic generation by truncated bessel beams in the sub-10-fs regime. Physical Review Letters 88(3): 033902

Masterson; Tanner; Patrick; Wieman 1993: High-brightness, high-purity spin-polarized cesium beam. Physical Review. A Atomic Molecular and Optical Physics 47(3): 2139-2145

Kennedy, J.S.; Stranahan, P.L.; Taylor, K.D.; Chandler, J.G. 1998: High-burst-strength, feedback-controlled bipolar vessel sealing. Surgical Endoscopy 12(6): 876-878

Ganzoni, A.; Heilig, P.; Schönenberger, K.; Hügli, O.; Fitting, J.W.; Brändli, O. 1994: High-caloric nutrition in chronic obstructive lung disease. Schweizerische Rundschau für Medizin Praxis 83(1): 13-16

Kochanek, S.; Schiedner, G.; Volpers, C. 2001: High-capacity 'gutless' adenoviral vectors. Current Opinion in Molecular Therapeutics 3(5): 454-463

Rey, M.A. 2001: High-capacity cation-exchange column for enhanced resolution of adjacent peaks of cations in ion chromatography. Journal of Chromatography. a 920(1-2): 61-68

Berridge, M.V.; Tan, A.S. 2000: High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. Antioxidants and Redox Signaling 2(2): 231-242

Lowenstein, P.R.; Thomas, C.E.; Umana, P.; Gerdes, C.A.; Verakis, T.; Boyer, O.; Tondeur, S.; Klatzmann, D.; Castro, M.G. 2002: High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain. Methods in Enzymology 346: 292-311

Poumay, Y.; Herphelin, F.; Smits, P.; De Potter, I.Y.; Pittelkow, M.R. 1999: High-cell-density phorbol ester and retinoic acid upregulate involucrin and downregulate suprabasal keratin 10 in autocrine cultures of human epidermal keratinocytes. Molecular Cell Biology Research Communications: Mcbrc 2(2): 138-144

Keyes 1990: High-chirality blue-phase lattices are unstable: a theory for the formation of blue phase IIi. Physical Review Letters 65(4): 436-439

Tanosaki, R.; Okamoto, S. 1996: High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy. Japanese Journal of Clinical Hematology 37(7): 591-597

Langmann, G.; Pendl, G.; Müllner, K.; Feichtinger, K.H.; Papaefthymiouaf, G. 2002: High-compared with low-dose radiosurgery for uveal melanomas. Journal of Neurosurgery 97(5 Suppl): 640-643

Jenkins, D.J.A.; Kendall, C.W.C.; Augustin, L.S.A.; Vuksan, V. 2002: High-complex carbohydrate or lente carbohydrate foods?. American Journal of Medicine 113 Suppl 9b: 30s-37s

Thomas, S. 1996: High-compression bandages. Journal of Wound Care 5(1): 40-43

Katayama, I.; Ohkawara, A.; Ohkido, M.; Harada, S.; Tamaki, K.; Nakagawa, H.; Hori, Y.; Nishiyama, S. 2002: High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids. European Journal of Dermatology: Ejd 12(6): 553-557

Quinones; Ford; Guiochon 2000: High-concentration band profiles and system peaks for a ternary solute system. Analytical Chemistry 72(7): 1495-1502

Nishio, M.; Choi, C.S.; Gevirtz, C.M. 1998: High-concentration cisatracurium in intensive care unit solution. Anesthesiology 89(6): 1605-1606

Chi, Z.; Liu, J.; Xu, P. 1995: High-concentration ethanol production from cooked corn starch by using medium-temperature cooking process. Chinese Journal of Biotechnology 11(3): 171-176

Ling 1994: High-concentration point-defect chemistry: Statistical-thermodynamic approach applied to nonstoichiometric cerium dioxides. Physical Review. B Condensed Matter 49(2): 864-880

Radwan, I.A.; Saito, S.; Goto, F. 2001: High-concentration tetracaine for the management of trigeminal neuralgia: quantitative assessment of sensory function after peripheral nerve block. Clinical Journal of Pain 17(4): 323-326

Günter, S.; Gude, A.; Maraschek, M.; Sesnic, S.; Zohm, H.; Howell, D.F. 2001: High-confinement regime at high beta(N) values due to a changed behavior of the neoclassical tearing modes. Physical Review Letters 87(27 Part 1): 275001

Johnston, J.R. 1994: High-conflict divorce. Future of Children 4(1): 165-182

Daria, V.R.; Miranda, J.J.; Saloma, C. 2002: High-contrast images of semiconductor sites via one-photon optical beam-induced current imaging and confocal reflectance microscopy. Applied Optics 41(20): 4157-4161

Natarajan; Behringer; Timp 1996: High-contrast, high-resolution focusing of neutral atoms using light forces. Physical Review. A Atomic Molecular and Optical Physics 53(6): 4381-4385

McManus, M.; Newacheck, P.; Kelly, R.; Macklin, M. 1992: High-cost children: the unknown liability. Business and Health 10(6): 28-30; 32-33

Mattera, M.D. 1996: High-cost health care?. Rn 59(7): 7

Thompson, C.A. 2002: High-cost sepsis drug forces pharmacists to weigh patients' future. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 59(8): 692; 697

Garfinkel, S.A.; Riley, G.F.; Iannacchione, V.G. 1988: High-cost users of medical care. Health Care Financing Review 9(4): 41-52

Tuman, K.J.; Ivankovich, A.D. 1993: High-cost, high-tech medicine: are we getting our money's worth?. Journal of Clinical Anesthesia 5(2): 168-177

Hornsey; Marsh; Cleaver; Ahmed 1995: High-current ballistic transport through variable-width constrictions in a high-mobility two-dimensional electron gas. Physical Review. B Condensed Matter 51(11): 7010-7016

Mensz; Tsui 1989: High-current effects in magnetotransport of two-dimensional electrons in GaAs/AlxGa1-xAs heterostructures. Physical Review. B Condensed Matter 40(6): 3919-3923

Sudan 1993: High-current ion-ring accelerator. Physical Review Letters 70(11): 1623-1626

SoRelle, R. 1998: High-definition television and telemetry. Circulation 98(6): 492

von Orelli, A.; Lehareinger, Y.; Rol, P.; Niederer, P.; Doswald, D.; Felber, N. 1999: High-definition true-colour television for use in minimally invasive medical procedures. Technology and Health Care: Official Journal of the European Society for Engineering and Medicine 7(1): 75-84

Ferrari, E.; Dupré-Minet, M.; Laffond, C.; Amselem, J.; Baudouy, M.; Morand, P. 1993: High-degree atrioventricular block revealing the first case of Lyme's disease in the Alpes-Maritimes department. Presse Medicale 22(3): 133

Fraunhofer, S.; Kiossis, D.; Helmberger, H.; von Sommoggy, S.; Maurer, P.C. 1994: High-degree bilateral carotid stenoses. Vasa. Zeitschrift für Gefasskrankheiten 23(2): 125-130

Van Belkum, A.; Troesch, A. 2003: High-density DNA arrays for comparative genomics and epidemiological studies in clinical microbiology. Expert Review of Molecular Diagnostics 3(1): 1-4

Krauser, J.T. 1996: High-density PTFE membranes: uses with root-form implants. Dental Implantology Update 7(9): 65-69

Steinmetz, L.M.; Davis, R.W. 2000: High-density arrays and insights into genome function. Biotechnology and Genetic Engineering Reviews 17: 109-146

Roy 1985: High-density behavior in supersymmetry. Physical Review. D Particles and Fields 31(4): 947-948

Le; Lax; Vojak; Calawa 1985: High-density excitonic state in two-dimensional multiple quantum wells. Physical Review. B Condensed Matter 32(2): 1419-1422

Leung; Pei 1989: High-density expansions of the relativistic Thomas-Fermi equation. Physical Review. A General Physics 40(5): 2731-2737

Ferguson, J.A.; Steemers, F.J.; Walt, D.R. 2000: High-density fiber-optic DNA random microsphere array. Analytical Chemistry 72(22): 5618-5624

Epstein, J.R.; Lee, M.; Walt, D.R. 2002: High-density fiber-optic genosensor microsphere array capable of zeptomole detection limits. Analytical Chemistry 74(8): 1836-1840

Banik, G.G.; Heath, C.A. 1996: High-density hybridoma perfusion culture. Limitation vs inhibition. Applied Biochemistry and Biotechnology 61(3): 211-229

Alvarez; Barbón; Nieto 1990: High-density limit of hot chiral matter. Physical Review. D Particles and Fields 42(4): 1215-1217

Bloomfield Rubins, H. 2000: High-density lipoprotein and coronary heart disease: lessons from recent intervention trials. Preventive Cardiology 3(1): 33-39

Dansky, H.M.; Fisher, E.A. 1999: High-density lipoprotein and plaque regression: the good cholesterol gets even better. Circulation 100(17): 1762-1763

Sheikh, K. 2001: High-density lipoprotein cholesterol and risk of stroke. JAMA 286(13): 1573-1574

Tonkin, A. 2001: High-density lipoprotein cholesterol and treatment guidelines. American Journal of Cardiology 88(12a): 41N-44N

Boden, W.E. 2000: High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial. American Journal of Cardiology 86(12a): 19l-22l

Medina; Nunes; Carrilho; Shimabukuru; Lottenberg; Lottenberg; McPherson; Krauss; Quintão 2000: High-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus. European Journal of Internal Medicine 11(5): 264-270

Zuliani, G.; Palmieri, E.; Volpato, S.; Bader, G.; Mezzetti, A.; Costantini, F.; Sforza, G.R.; Imbastaro, T.; Romagnoni, F.; Fellin, R. 1997: High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: a cross sectional study. Associazione Medica Sabin. Aging 9(5): 335-341

Watts, G.F.; Barrett, P.H. 2002: High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 12(1): 36-41

Ko, Y.; Häring, R.; Stiebler, H.; Wieczorek, A.J.; Vetter, H.; Sachinidis, A. 1993: High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Atherosclerosis 99(2): 253-259

Silverman, D.I.; Ginsburg, G.S.; Pasternak, R.C. 1993: High-density lipoprotein subfractions. American Journal of Medicine 94(6): 636-645

Benvenga, S.; Alesci, S.; Trimarchi, F. 2002: High-density lipoprotein-facilitated entry of thyroid hormones into cells: a mechanism different from the low-density lipoprotein-facilitated entry. Thyroid: Official Journal of the American Thyroid Association 12(7): 547-556

Toth, P.P. 2001: High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects. Disease-A-Month: Dm 47(8): 369-416

Ivanchenkova, R.A.; Sviridov, A.V.; Ozerova, I.N.; Perova, N.V.; Grachev, S.V. 2000: High-density lipoproteins in cholesterosis of the gall bladder. Klinicheskaia Meditsina 78(4): 27-31

Matzilevich, D.A.; Rall, J.M.; Moore, A.N.; Grill, R.J.; Dash, P.K. 2002: High-density microarray analysis of hippocampal gene expression following experimental brain injury. Journal of Neuroscience Research 67(5): 646-663

Pantoliano, M.W.; Petrella, E.C.; Kwasnoski, J.D.; Lobanov, V.S.; Myslik, J.; Graf, E.; Carver, T.; Asel, E.; Springer, B.A.; Lane, P.; Salemme, F.R. 2001: High-density miniaturized thermal shift assays as a general strategy for drug discovery. Journal of Biomolecular Screening 6(6): 429-440

Peng, J.H.; Fahima, T.; Röder; Huang, Q.Y.; Dahan, A.; Li, Y.C.; Grama, A.; Nevo, E. 2000: High-density molecular map of chromosome region harboring stripe-rust resistance genes YrH52 and Yr15 derived from wild emmer wheat, Triticum dicoccoides. Genetica 109(3): 199-210

Burton, S.S.; Liebig, T.; Frazier, S.D.; Ros, P.R. 1997: High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting. Magnetic Resonance Imaging 15(2): 147-153

Zhang, J.; Collins, A.; Chen, M.; Knyazev, I.; Gentz, R. 1998: High-density perfusion culture of insect cells with a biosep ultrasonic filter. Biotechnology and Bioengineering 59(3): 351-359

Odum, B.C.; Bussard, G.M.; Lewis, R.P.; Lara, W.C.; Edlich, R.F.; Gampper, T.J. 1998: High-density porous polyethylene for facial bone augmentation. Journal of Long-Term Effects of Medical Implants 8(1): 3-17

Poelker; Coulter; Holt; Jones; Kowalczyk; Young; Zeidman; Toporkov 1994: High-density production of spin-polarized atomic hydrogen and deuterium. Physical Review. A Atomic Molecular and Optical Physics 50(3): 2450-2458

Rosenfeld 1986: High-density properties of integral-equation theories of fluids: Universal analytic structure and details for the one-component plasma. Physical Review. A General Physics 33(3): 2025-2042

Rosenfeld 1985: High-density properties of liquid-state theories: Physically intuitive meaning for the direct correlation functions. Physical Review. A General Physics 32(3): 1834-1842

Demontis; Klein; LeSar 1989: High-density structures and phase transition in an ionic model of H2O ice. Physical Review. B Condensed Matter 40(4): 2716-2718

Fruchtman 1988: High-density thick-beam free-electron laser. Physical Review. A General Physics 37(11): 4259-4264

Townsend; Edwards; Zetie; Cooper; Rink; Foot 1996: High-density trapping of cesium atoms in a dark magneto-optical trap. Physical Review. A Atomic Molecular and Optical Physics 53(3): 1702-1714

Takasu, Y.; Honda, K.; Komori, K.; Kuwamoto, T.; Kumakura, M.; Takahashi, Y.; Yabuzaki, T. 2003: High-density trapping of cold ytterbium atoms by an optical dipole force. Physical Review Letters 90(2): 023003

Abele-Horn, M.; Scholz, M.; Wolff, C.; Kolben, M. 2000: High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery. Acta Obstetricia et Gynecologica Scandinavica 79(11): 973-978

Wu, S.-Y.; Ho, J.-D.; Ho, C.-L.; Chen, S.-N.; Tsai, R.J.-f. 2002: High-density vitreous substitute in the management of advanced Coats' disease. Chang Gung Medical Journal 25(2): 128-132

Nion, S.; Briand, O.; Lestavel, S.; Torpier, G.; Nazih, F.; Delbart, C.; Fruchart, J.C.; Clavey, V. 1997: High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins. Biochemical Journal 328: 415-423

Richardson, L.Y. 2002: High-dependency care: developing a joint surgical recovery unit. British Journal of Nursing 11(2): 129-134

Elliott, M. 1997: High-dependency nursing. Australian Critical Care: Official Journal of the Confederation of Australian Critical Care Nurses 10(2): 48

Prien, T. 1998: High-dependency units: reducing the cost of intensive care without loss of quality. European Journal of Anaesthesiology 15(6): 753-755

Orsholm; Csillag; Borglund 2000: High-detective-quantum-efficiency fast-electron detector for electron energy loss spectroscopy. Micron 31(4): 441-450

Yang, Y.; Stark, H.; Gurkan, D.; Lawson, C.L.; Cohn, R.W. 2000: High-diffraction-efficiency pseudorandom encoding. Journal of the Optical Society of America. A Optics Image Science and Vision 17(2): 285-293

Le Berre M; Ressayre; Tallet; Gibbs 1986: High-dimension chaotic attractors of a nonlinear ring cavity. Physical Review Letters 56(4): 274-277

Fischer; Hess; Elsa; Göbel 1994: High-dimensional chaotic dynamics of an external cavity semiconductor laser. Physical Review Letters 73(16): 2188-2191

Ashburner, J.; Andersson, J.L.; Friston, K.J. 1999: High-dimensional image registration using symmetric priors. Neuroimage 9(6 Part 1): 619-628

Chian, A.C.-L.; Rempel, E.L.; Macau, E.E.; Rosa, R.R.; Christiansen, F. 2002: High-dimensional interior crisis in the Kuramoto-Sivashinsky equation. Physical Review. e Statistical Nonlinear and Soft Matter Physics 65(3 Pt 2a): 035203

Posener, J.A.; Wang, L.; Price, J.L.; Gado, M.H.; Province, M.A.; Miller, M.I.; Babb, C.M.; Csernansky, J.G. 2003: High-dimensional mapping of the hippocampus in depression. American Journal of Psychiatry 160(1): 83-89

Kieser, J.A.; Groeneveld, H.T. 1992: High-dimensional plots in the evaluation of interpopulation differences in human tooth size. Journal of the Dental Association of South Africa 47(8): 361-364

Gross; Hammer; Scheffler; Brenig 1994: High-dimensional quantum dynamics of adsorption and desorption of H2 at Cu(111). Physical Review Letters 73(23): 3121-3124

Solano, C.; Sola, C.; Lluch, A.; Hornedo, J.; López, J.; Cortés-Funes, H.; García-Conde, J. 1997: High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative study. Sangre 42(Suppl 1): 53-56

Sola, C.; Ojeda, B.; Brunet, J.; López López, J.J. 1997: High-dosage chemotherapy in breast cancer. Medicina Clinica 108(10): 398-399

Van der Hoeven, J.G.; Compier, E.A.; Meinders, A.E. 1993: High-dosage epinephrine in patients with cardiopulmonary arrest outside of the hospital?. Nederlands Tijdschrift Voor Geneeskunde 137(9): 439-442

Müller, C.; Axthelm, E.H. 1995: High-dosage systemic lysis of a fulminant pulmonary embolism in an echocardiographically recognized mobile thrombus of the right heart. Deutsche Medizinische Wochenschrift 120(50): 1758

Hossfeld, D.K. 2001: High-dosage treatment of breast cancer - against. Deutsche Medizinische Wochenschrift 126(39): 1092

Zander, A.R.; Kröger, N. 2001: High-dosage treatment of breast cancer--in favour. Deutsche Medizinische Wochenschrift 126(39): 1091

Trehan, M.; Taylor, C.R. 2002: High-dose 308-nm excimer laser for the treatment of psoriasis. Journal of the American Academy of Dermatology 46(5): 732-737

Hofheinz, R.-D.; Hartung, G.; Samel, S.; Hochhaus, A.; Pichlmeier, U.; Post, S.; Hehlmann, R.; Queisser, W. 2002: High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. a phase Ii study. Onkologie 25(3): 255-260

Navis, G.; Kramer, A.B.; de Jong, P.E. 2002: High-dose ACE inhibition: can it improve renoprotection?. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 40(3): 664-666

Argiris, A.; Seropian, S.; Cooper, D.L. 2000: High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(6): 665-672

Fields; Agaliotis; Janssen; Perkins; Ballester; Hiemenz; Zorsky; Elfenbein 1994: High-dose Chemotherapy and the Treatment of Metastatic Breast Cancer: Selecting the Regimen and the Source of Stem Cells. Cancer Control: Journal of the Moffitt Cancer Center 1(3): 213-218

Tauchert, M.; Gildor, A.; Lipinski, J. 1999: High-dose Crataegus extract WS 1442 in the treatment of NYHA stage Ii heart failure. Herz 24(6): 465-474; Discussion 475

Leissinger, C.; Becton, D.; Cornell, C.; Cox Gill, J. 2001: High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A. Haemophilia: the Official Journal of the World Federation of Hemophilia 7(3): 258-266

Harmon, K.S. 1999: Comparing the epidemic in U.S. and Britain. Positively Aware: the Monthly Journal of the Test Positive Aware Network 10(3): 54-56

Black, W.C. 1994: High-dose MR in the evaluation of brain metastases: will increased detection decrease costs?. Ajnr. American Journal of Neuroradiology 15(6): 1062-1064

Tepe; Dinkelborg; Muschik; Dietrich; Claussen; Noll; Wiskirchen; Duda 2001: High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty. Cardiovascular Radiation Medicine 2(1): 54

Reeker, W.; Werner, C.; Möllenberg, O.; Mielke, L.; Kochs, E. 2000: High-dose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia in rats. Canadian Journal of Anaesthesia 47(6): 572-578

Weeston, T.F.; Constantino, J. 1996: High-dose T4 for rapid-cycling bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 35(2): 131-132

Stege, H.; Schöpf, E.; Ruzicka, T.; Krutmann, J. 1996: High-dose UVA1 for urticaria pigmentosa. Lancet 347(8993): 64

Barkholt, L.; Lewensohn-Fuchs, I.; Ericzon, B.G.; Tydén, G.; Andersson, J. 1999: High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients. Transplant Infectious Disease: An Official Journal of the Transplantation Society 1(2): 89-97

Abeloff, M.D. 1993: High-dose adjuvant chemotherapy for high-risk breast cancer. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 127: 177-183

Anonymous 2000: High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question. Clinical breast cancer 1(3): 191-192

Licata, A.G. 1998: High-dose adjuvant interferon therapy for melanoma. Dermatology Nursing 10(5): 334-336

Lipman, J.; Wilson, W.; Kobilski, S.; Scribante, J.; Lee, C.; Kraus, P.; Cooper, J.; Barr, J.; Moyes, D. 1993: High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation: a double-blind randomised trial. Anaesthesia and Intensive Care 21(2): 192-196

Joynt, G.; Doedens, L.; Lipman, J.; Bothma, P. 1996: High-dose adrenaline with low systemic vascular resistance and symmetrical peripheral gangrene. South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 34(2): 99-101

Fisher, R.I.; Rosenberg, S.A.; Sznol, M.; Parkinson, D.R.; Fyfe, G. 1997: High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer Journal from Scientific American 3 Suppl. 1: S70-S72

Argilés, A.; Lorho, R.; Mourad, G.; Mion, C.M. 1993: High-dose alfacalcidol for anaemia in dialysis. Lancet 342(8867): 378-379

Reed, M.D. 1999: High-dose amoxicillin in new guidelines for treatment of otitis media in children. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 56(22): 2351

Herranz, M.T.; Molina, M.A.; Corrales, A.; Almagro, M. 1998: High-dose amphotericin B in the treatment of rhino-cerebral mucormycosis: a case with an unusual evolution. Anales de Medicina Interna 15(2): 115-116

Radosavljević, D.; Jelić, S.; Tomasević, Z.; Matković, S.; Stamatović, L.; Nikolić-Tomasević, Z.; Popov, I. 2000: High-dose anthracyclines in the treatment of advanced primitive neuroectodermal tumors in adults--a single institution experience. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 6(3): 512-518

Iba, T.; Kidokoro, A. 2000: High-dose antithrombin therapy for sepsis. Journal of Trauma 49(5): 979-980

Iba, T.; Kidokoro, A. 2002: High-dose antithrombin therapy for sepsis: mechanisms of action. Shock 18(5): 389-394

Tassani, P.; Augustin, N.; Barankay, A.; Braun, S.L.; Zaccaria, F.; Richter, J.A. 2000: High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 14(6): 682-686

Shulman, S.T. 1999: High-dose aspirin in Kawasaki disease. Journal of Pediatrics 134(4): 523-524

Kavløy, S.; Holte, H.; Kvalheim, G. 1994: High-dose autologous stem cell support in malignant diseases--an established method, uncertain indication. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(19): 2240-2241

Saito, N.; Takemori, N.; Hirai, K.; Onodera, R.; Watanabe, S.; Kohgo, Y. 1996: High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura. American Journal of Hematology 51(2): 173-174

Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529

Marrouche, N.F.; Reddy, R.K.; Wittkowsky, A.K.; Bardy, G.H. 2000: High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial. American Heart Journal 139(6): E8-11

Schnider, P.; Moraru, E.; Kittler, H.; Voller, B.; Auff, E. 2000: High-dose botulinum toxin type a for axillary hyperhidrosis. Archives of Dermatology 136(12): 1567

Wollina, U.; Karamfilov, T.; Konrad, H. 2002: High-dose botulinum toxin type a therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. Journal of the American Academy of Dermatology 46(4): 536-540

Corsa, P.; Parisi, S.S.; Raguso, A.; el Jaouni, M.; Fusco, V.; Maiorana, A.; Lauriola, P.; Di Corcia, A.; Di Cosmo, V.; Albano, A. 1997: High-dose brachytherapy in endobronchial neoplastic stenoses. La Radiologia Medica 94(1-2): 94-99

Micke, O.; Schäfer, U.; Prott, F.J.; Wassmann, H.; Willich, N. 1999: High-dose brachytherapy in malignant brain tumors--history, procedure and personal experience. Rontgenpraxis; Zeitschrift für Radiologische Technik 52(2): 63-70

Ikuta, K.; Fujioka, K.; Sumita, H.; Takahashi, H.; Sekiguchi, H.; Kai, S.; Kajigaya, Y.; Funabiki, T.; Sakai, H.; Matsuyama, S. 1993: High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia. Japanese Journal of Clinical Hematology 34(5): 636-642

Schiffman, K.; Buckner, C.D.; Maziarz, R.; Maloney, D.G.; Appelbaum, F.R.; Press, O.; Gooley, T.; Holmberg, L.; Lilleby, K.; Clift, R.; Zuckerman, N.; Klarnet, J.; Weaver, C.; Chauncey, T.; Bensinger, W.I. 1997: High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 3(5): 261-266

Kalous, O.; Mayer, J.; Malásková, L. 2001: High-dose busulfan--monitoring plasma levels and dosage adjustments in adults. Casopis Lekaru Ceskych 140(23): 724-728

Benazzo, M.; Bernardo, G.; Corbella, F.; Danova, M.; Lanza, L.; Zappoli, F.; Uggetti, C.; Mira, E. 1996: High-dose carboplatin superselective intraarterial chemotherapy in advanced head and neck cancer. Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 16(1): 30-34

Siegert, W. 1993: High-dose carboplatin, etoposide and ifosfamide and autologous stem cell rescue in the treatment of non-Hodgkin lymphoma. Pathologie-Biologie 41(1): 104

Dunkel, I.J.; Boyett, J.M.; Yates, A.; Rosenblum, M.; Garvin, J.H.; Bostrom, B.C.; Goldman, S.; Sender, L.S.; Gardner, S.L.; Li, H.; Allen, J.C.; Finlay, J.L. 1998: High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(1): 222-228

Arnold, K. 1999: High-dose chemo and breast cancer: early results spark debate. Journal of the National Cancer Institute 91(12): 992-994

Nademanee, A.; Molina, A.; Fung, H.; Stein, A.; Parker, P.; Planas, I.; O'Donnell, M.R.; Snyder, D.S.; Kashyap, A.; Spielberger, R.; Bhatia, R.; Krishnan, A.; Sniecinski, I.; Vora, N.; Slovak, M.; Dagis, A.; Niland, J.C.; Forman, S.J. 1999: High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 5(5): 292-298

Burdach, S.; Jürgens, H. 2002: High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Critical Reviews in Oncology/Hematology 41(2): 169-189

Freedman, A.S.; Neuberg, D.; Gribben, J.G.; Mauch, P.; Soiffer, R.J.; Fisher, D.C.; Anderson, K.C.; Andersen, N.; Schlossman, R.; Kroon, M.; Ritz, J.; Aster, J.; Nadler, L.M. 1998: High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(1): 13-18

Tanosaki, R.; Okamoto, S.; Takahashi, S.; Inoue, T.; Kikuno, K.; Aoki, Y.; Takada, M.; Irie, S.; Shimane, M.; Tojo, A. 1993: High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML). Japanese Journal of Clinical Hematology 34(8): 946-951

Douer, D.; Levine, A.; Anderson, W.F.; Gordon, M.; Groshen, S.; Khan, A.; Mohrbacher, A.; Muggia, F.; Shibata, D. 1996: High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults. Human Gene Therapy 7(5): 669-684

Handberg, J.; Hansen, S.W. 1996: High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. a review. Ugeskrift for Laeger 158(29): 4175-4180

Decatris, M.P.; Wilkinson, P.M.; Welch, R.S.; Metzner, M.; Morgenstern, G.R.; Dougall, M. 2000: High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(4): 427-434

De Castro, C.áu.G.ão.; de Almeida, S.G.; Gregianin, L.J.é; Loss, J.F.; Rivero, L.ís.F.; Schwartsmann, G.; Brunetto, A.L. 2003: High-dose chemotherapy and autologous peripheral blood stem cell rescue in a patient with pleuropulmonary blastoma. Journal of Pediatric Hematology/Oncology 25(1): 78-81

Tanaka, K.; Matsunobu, T.; Sakamoto, A.; Matsuda, S.; Iwamoto, Y. 2002: High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors. Journal of orthopaedic science: official journal of the Japanese Orthopaedic Association 7(4): 477-482

Hwang, Y.K.; Goh, Y.T.; Linn, Y.C.; Tan, C.H.; Tan, H.C. 2000: High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option. Transplantation Proceedings 32(7): 2464-2466

DeMagalhaes-Silverman, M.; Bloom, E.; Lembersky, B.; Lister, J.; Pincus, S.; Rybka, W.; Voloshin, M.; Wilson, J.; Ball, E. 1997: High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(2): 193-197

Avigdor, A.; Hardan, I.; Shpilberg, O.; Raanani, P.; Grotto, I.; Ben-Bassat, I. 2000: High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer. Harefuah 139(5-6): 174-179; 248, 247

Vose, J.M.; Armitage, J.O.; Kessinger, A. 1993: High-dose chemotherapy and autologous transplant with peripheral-blood stem cells. Oncology 7(8): 23-29; Discussion: 29-30, 33-34

Gianni, A.M. 1997: High-dose chemotherapy and autotransplants: a time for guidelines. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(10): 933-935

Ravaud, P.; Fermand, J.P. 1993: High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits. Revue du Rhumatisme 60(4): 266-268

Gradishar, W.J. 1999: High-dose chemotherapy and breast cancer. JAMA 282(14): 1378-1380

Damon, L.E.; Hu, W.W.; Stockerl-Goldstein, K.E.; Blume, K.G.; Wolf, J.L.; Gold, E.; Cecchi, G.R.; Irwin, D.; Glaspy, J.; Territo, I.; Miller, W.; Mason, J.R.; Linker, C.A. 2000: High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 6(5): 496-505

Mugishima, H. 1999: High-dose chemotherapy and hematopoietic stem cell transplant in the treatment of advanced neuroblastoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(8): 1056-1067

Vose, J.M. 1998: High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(Suppl 1): S1-S3

Stuart, M.J.; Peters, W.P.; Broadwater, G.; Hussein, A.; Ross, M.; Marks, L.B.; Folz, R.J.; Long, G.D.; Rizzieri, D.; Chao, N.J.; Vredenburgh, J.J. 2002: High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 8(12): 666-673

Peters, W.P.; Dansey, R.D.; Klein, J.L.; Baynes, R.D. 2000: High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer. Oncologist 5(1): 1-13

Rosti, G.; Ferrante, P.; Tienghi, A.; Turci, D.; Dazzi, C.; Leoni, M.; Fiorentini, G.; Ferrari, E.; Zornetta, L.; Marangolo, M. 1996: High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors. Tumori 82(2 Suppl): S19-S22

Pont, J.; Höltl, W.; Weissbach, L.; Beyer, J.; Siegert, W. 1997: High-dose chemotherapy and reinfusion of hematopoietic stem cells in advanced germ cells tumors with poor prognosis--the position in 1996. Der Urologe. Ausg. a 36(6): 561-564

Turkina, E.V.; Rybnikova, E.A.; Rakitskaia, V.V.; Shaliapina, V.G. 1996: The participation of the neostriatum in realizing the action of corticoliberin on the hormonal function of the adrenal glands. Fiziologicheskii Zhurnal Imeni I.M. Sechenova 82(5-6): 109-113

Pedrazzoli, P.; Da Prada, G.A.; Robustelli della Cuna, G. 1998: High-dose chemotherapy and stem-cell support in breast cancer. Lancet 352(9135): 1220

Stiff, P.J.; Bayer, R.; Tan, S.; Camarda, M.; Sosman, J.; Peace, D.; Kinch, L.; Rad, N.; Loutfi, S. 1995: High-dose chemotherapy combined with escalating doses of cyclosporin a and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase i clinical trial. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(12): 1495-1502

Bierman, P.J.; Anderson, J.R.; Freeman, M.B.; Vose, J.M.; Kessinger, A.; Bishop, M.R.; Armitage, J.O. 1996: High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(2): 151-156

Van den Hoogen, F.H.; Schattenberg, A.V.; Breedveld, F.C.; Fibbe, W.E.; van de Putte, L.B. 1997: High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases. Nederlands Tijdschrift Voor Geneeskunde 141(43): 2061-2065

Matsuura, H.; Sakurai, M.; Arima, K. 1999: High-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced extragonadal germ cell tumor--a case report. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 90(4): 521-525

Jillella, A.P.; Helman, S.W.; Larison, J.; Litaker, M.S.; Cook, L.O. 2000: High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period. Journal of HematoTherapy and Stem Cell Research 9(6): 849-854

Bearman, S.I. 2000: High-dose chemotherapy for breast cancer. Lancet 356(9229): 595-596

Durant, J.R. 1999: High-dose chemotherapy for breast cancer in USA. Lancet 354(9174): 252-253

Gianni, L. 2002: High-dose chemotherapy for breast cancer: any use for it?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(5): 650-652

Lopez, M. 1999: High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?. La Clinica Terapeutica 150(4): 259-262

Martin, M. 1995: High-dose chemotherapy for breast cancer: clinical advantages of autologous peripheral blood progenitor cells (PBPC) compared with autologous bone marrow transplantation (ABMT). Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(Suppl 4): 33-37

Antman, K.; Tiersten, A. 1999: High-dose chemotherapy for breast cancer: evolving data. Oncology 13(9): 1215-1219

Bearman, S.I. 2000: High-dose chemotherapy for breast cancer: we have not heard the final word. Cancer Investigation 18(5): 494-497

Norton, L. 2001: High-dose chemotherapy for breast cancer: "how do you know?". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(11): 2769-2770

Byers, T.; Vance, R.; Bigelow, C. 2000: High-dose chemotherapy for breast cancer?. Cancer Practice 8(2): 96-98

Khouri, I.F.; Keating, M.J. 1998: High-dose chemotherapy for chronic lymphocytic leukemia: eligibility, timing, and benefit?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(2): 131-132

Motzer, R.J. 1996: High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center. Bone Marrow Transplantation 18 Suppl. 1: S53-S54

Recht, A. 1996: High-dose chemotherapy for metastatic breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(2): 684-685

Kleeberg, U.R. 2000: High-dose chemotherapy for metastatic breast cancer without certain advantages so far. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(7): 334-335

Aebi, S.; Castiglione-Gertsch, M. 2001: High-dose chemotherapy for ovarian cancer: are we ready to go?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 583-584

Ledermann, J.A.; Herd, R.; Maraninchi, D.; Viens, P.; Buclon, M.; Philip, T.; Cure, H.; Lotz, J.P.; Chauvin, F.; Ferrante, P.; Rosti, G. 2001: High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 693-699

Hortobagyi, G.N. 1999: High-dose chemotherapy for primary breast cancer: facts versus anecdotes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(11 Suppl): 25-29

Mackall, C.L.; Helman, L.J. 2001: High-dose chemotherapy for rhabdomyosarcoma: where do we go from here. Journal of Pediatric Hematology/Oncology 23(5): 266-267

Siegert, W.; Rick, O.; Beyer, J. 1998: High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin. Bone Marrow Transplantation 22(Suppl 4): S7-S9

Burtness, B. 1999: High-dose chemotherapy for the treatment of high-risk and advanced breast cancer. Connecticut Medicine 63(1): 41-46

Tajima, T.; Ohta, M.; Tokuda, Y. 2000: High-dose chemotherapy for treatment of breast cancers. Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 223-227

Bay, J.O.; Blay, J.Y. 2001: High-dose chemotherapy for tumor treatment: the end of the beginning ?. Bulletin du Cancer 88(9): 821

Charnay-Sonnek, F. 1998: High-dose chemotherapy in a day clinic. Pflege Aktuell 52(11): 621-623

Curé, H.; Bay, J.O.; Plagne, R.; Chollet, P.; Dauplat, J. 2001: High-dose chemotherapy in advanced epithelial ovarian cancer. Bulletin du Cancer 88(9): 842-851

Schmid, P.; Possinger, K. 2002: High-dose chemotherapy in breast cancer. Medizinische Klinik 97(11): 677-686

Miller, K.D.; Sledge, G.W. 2000: High-dose chemotherapy in breast cancer -- the perils of history uncontrolled. Medscape Women's Health 5(3): E1

Rodenhuis, S. 2001: High-dose chemotherapy in breast cancer--interpretation of the randomized trials. Anti-Cancer Drugs 12(2): 85-88

Antman, K.H. 2000: High-dose chemotherapy in breast cancer: the end of the beginning?. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 6(5): 469-475

Lelli, G. 2000: High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows. Recenti Progressi in Medicina 91(12): 647-649

Rick, O.; Beyer, J.; Kingreen, D.; Schwella, N.; Krusch, A.; Schleicher, J.; Kirsch, A.; Huhn, D.; Siegert, W. 1998: High-dose chemotherapy in germ cell tumours: a large single centre experience. European Journal of Cancer 34(12): 1883-1888

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J. 1998: High-dose chemotherapy in gynecologic malignancies. Cancer Treatment and Research 95: 277-285

Price, L.A. 1998: High-dose chemotherapy in high-risk breast cancer. Lancet 352(9139): 1551-1552

Rowlings, P.A. 1998: High-dose chemotherapy in metastatic breast cancer. Lancet 351(9117): 1733

Leonard, R.C. 1998: High-dose chemotherapy in metastatic breast cancer. Lancet 351(9107): 986

Blay, J.Y.; Philip, T.O. 1996: High-dose chemotherapy in non-Hodgkin's lymphoma. Cancer Treatment and Research 85: 87-103

Espinosa Arranz, E.; González Barón, M. 2001: High-dose chemotherapy in nonhematologic tumors. Revista Clinica Espanola 201(2): 93-94

Lotz, J.P.; Lhommé, C.; Pautier, P.; Couteau, C.; Gligorov, J.; Alexandre, J.; Selle, F.; Izrael, V.; Maraninchi, D.; Viens, P. 2000: High-dose chemotherapy in ovarian adenocarcinoma. Bulletin du Cancer 87(1): 63-69

Donato, M.L. 2003: High-dose chemotherapy in ovarian cancer: still waiting for the right study. Gynecologic Oncology 88(1): 1-2

Herrin, V.E.; Thigpen, J.T. 1999: High-dose chemotherapy in ovarian carcinoma. Seminars in Oncology 26(1): 99-105

Bertuzzi, A.; Castagna, L.; Nozza, A.; Quagliuolo, V.; Siracusano, L.; Balzarotti, M.; Compasso, S.; Alloisio, M.; Soto Parra, H.; Santoro, A. 2002: High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(8): 2181-2188

Srinivas, S. 2000: High-dose chemotherapy in poor-risk germ-cell tumors. Oncology 14(10): 1419-1423; Discussion: 1427-1430; 1433-1434

Dupuis-Girod, S.; Hartmann, O.; Benhamou, E.; Doz, F.; Mechinaud, F.; Bouffet, E.; Coze, C.; Kalifa, C. 1997: High-dose chemotherapy in relapse of medulloblastoma in young children. Bulletin du Cancer 84(3): 264-272

Pasini, F.; Durante, E.; De Manzoni, D.; Rosti, G.; Pelosi, G. 2002: High-dose chemotherapy in small-cell lung cancer. Anticancer Research 22(6b): 3465-3472

Ray-Coquard, I.; Biron, P.; Blay, J.Y. 2001: High-dose chemotherapy in soft tissue sarcomas of adults. Bulletin du Cancer 88(9): 858-862

Jense, T.S. 1996: High-dose chemotherapy in solid tumors--a therapeutic breakthrough?. Ugeskrift for Laeger 158(29): 4169

Hamilton, K.; Iskandar, B. 2018: Amenorrhoea and reversible infertility due to obstructive hydrocephalus: literature review and case report. British Journal of Neurosurgery 32(3): 291-294

Kabícková, E.; Kavan, P.; Koutecký, J.; Malis, J.; Stanková, J.; Gajdos, P.; Kodet, R.; Cumlivská, E. 2000: High-dose chemotherapy in the treatment of children with malignant lymphoma. Casopis Lekaru Ceskych 139(20): 623-629

Fagioli, F.; Aglietta, M.; Tienghi, A.; Ferrari, S.; Brach del Prever, A.; Vassallo, E.; Palmero, A.; Biasin, E.; Bacci, G.; Picci, P.; Madon, E. 2002: High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(8): 2150-2156

Crown, J.; Raptis, G.; Hamilton, N.; Hudis, C.; Vahclat, L.; Fennelly, D.; Norton, L. 1995: High-dose chemotherapy of breast cancer. Canadian Journal of Oncology 5(Suppl 1): 80-82

Antimi, M. 1998: High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives. La Clinica Terapeutica 149(921): 7-9

Tartarone, A.; Aieta, M.; Morritti, M.G.; Palomba, G.; Romano, M.P.; Lelli, G. 1998: High-dose chemotherapy of metastatic breast carcinoma. La Clinica Terapeutica 149(3): 227-230

Heyll, A.; Söhngen, D.; Aul, C.; Schneider, P.; Kobbe, G.; Bauser, U.; Quenzel, E.M.; Schneider, W. 1998: High-dose chemotherapy of patients with multiple myeloma. Praxis 87(25-26): 879-883

Crown, J. 1995: High-dose chemotherapy of solid tumours. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(Suppl 1): 11-14; Discussion: 14-15

Anonymous 2002: High-dose chemotherapy plus allogeneic stem cells to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. Tec Bulletin 19(1): 5-9

Lippman, M.E. 2000: High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. New England Journal of Medicine 342(15): 1119-1120

Brodowicz, T.; Auerbach, L.; Zielinski, C. 2000: High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer. New England Journal of Medicine 343(6): 439

Kim, S.; Shiba, E.; Taguchi, T.; Kimoto, Y.; Inoue, T.; Shimazu, K.; Takamura, Y.; Tanji, Y.; Izukura, M.; Ogawa, H.; Sugiyama, H.; Kubota, T.; Kimura, T.; Takai, S. 1996: High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(5): 635-638

Cameron, D.A.; Craig, J.; Gabra, H.; Lee, L.; MacKay, J.; Parker, A.C.; Leonard, R.C.; Anderson, E.; Anderson, T.; Chetty, U.; Dixon, M.; Hawkins, A.; Jack, W.; Kunkler, I.; Leonard, R.; Matheson, L.; Miller, W. 1996: High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group. British journal of cancer 74(12): 2013-2017

Anand, A. 1993: High-dose chemotherapy with autologous bone marrow support in node-positive melanoma. Journal of the National Cancer Institute 85(23): 1961

Aleĭnikova, O.V.; Strongin, I.S.; Pochetukhin, K.V. 2002: High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations. Voprosy Onkologii 48(3): 327-330

Jost, L.M.; Honegger, H.P.; Stahel, R.A. 2000: High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich. Schweizerische Medizinische Wochenschrift 130(3): 60-69

Basade, M.M.; Gulati, S.C. 1996: High-dose chemotherapy with autologous bone marrow/stem-cell rescue in lung cancer. Lancet 347(9005): 847-848

Gorczyńska, E.; Toporski, J.; Bogusławska-Jaworska, J.; Słociak, M. 1998: High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results. Bone Marrow Transplantation 22(Suppl 4): S107-S109

Kochi; Ushio 1999: High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors. Critical Reviews in Neurosurgery: Cr 9(5): 295-302

Crump, M.; Gluck, S.; Pritchard, K.; Shepherd, L.; Pater, J. 1998: High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(2): 800-802

Akasaka, Y.; Madarame, J.; Yanada, S.; Igarashi, H.; Kuroda, A.; Nakata, J.; Ohishi, Y.; Kondou, N.; Tomita, M. 1998: High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(11): 1739-1745

Yonemoto, T.; Tatezaki, S.; Ishii, T.; Satoh, T. 1999: High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1431-1435

Yamane, T.; Hino, M.; Ohta, K.; Koh, K.R.; Nakamae, H.; Aoyama, Y.; Ota, T.; Kishida, T.; Mugitani, A.; Sannomiya, Y.; Kamitani, T.; Takubo, T.; Tatsumi, N. 2000: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(10): 1547-1555

Uno, H.; Fujita, M.; Hino, N.; Nakagawa, H.; Miyagawa, H.; Aoki, J.; Taniyama, K.; Sasaki, N. 1999: High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination. Japanese Journal of Clinical Hematology 40(7): 556-562

Dunkel, I.J. 2000: High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors. Cancer Investigation 18(5): 492-493

Kortmann, R.D. 1997: High-dose chemotherapy with autologous stem cell rescue in patients with recurrent and high-risk pediatric brain tumors. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 173(10): 531-532

Dix, S.P.; Geller, R.B. 2000: High-dose chemotherapy with autologous stem cell rescue in the outpatient setting. Oncology 14(2): 171-185; Discussion: 185-186; 191-192

Ayash, L.J.; Elias, A.; Wheeler, C.; Tepler, I.; Schwartz, G.; Schnipper, L.; Frei, E.; Antman, K. 1993: High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Journal of HematoTherapy 2(4): 507-511

Schrader, A.J.; Atzpodien, J. 2000: High-dose chemotherapy with autologous stem-cell transplantation in patients with pretreated advanced malignant melanoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(10): 1361-1362

Torello, E.; Koziner, B. 1993: High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL. Sangre 38(6): 473-480

Namouni, F.; Doz, F.; Tanguy, M.L.; Quintana, E.; Michon, J.; Pacquement, H.; Bouffet, E.; Gentet, J.C.; Plantaz, D.; Lutz, P.; Vannier, J.P.; Validire, P.; Neuenschwander, S.; Desjardins, L.; Zucker, J.M. 1997: High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. European Journal of Cancer 33(14): 2368-2375

Martín, M.; Casado, A.; Llorente, L.; López Martín, J.A.; Rodríguez Lescure, A.; Nieto, Y.; Ayala, F.; Pérez Calvo, J.; Alonso, J.L.; Pérez López, C.; Villegas, A.; Díaz-Rubio, E. 1997: High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer. Medicina Clinica 109(20): 775-781

Bezwoda, W.R. 1997: High-dose chemotherapy with haematopoietic rescue: application to primary management of metastatic breast cancer. European Journal of Cancer Care 6(4 Suppl): 10-15

Perey, L.; Leyvraz, S. 1995: High-dose chemotherapy with hematopoietic salvage in patients with breast cancer. Praxis 84(9): 259-263

Takenaka, K.; Shinagawa, K.; Maeda, Y.; Makita, M.; Kozuka, T.; Ashiba, A.; Yamamoto, K.; Fujii, N.; Nawa, Y.; Hiramatsu, Y.; Sunami, K.; Ishimaru, F.; Yoshimo, T.; Kiura, K.; Harada, M. 2001: High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leukemia and Lymphoma 42(6): 1297-1303

Viens, P.; Maraninchi, D. 2001: High-dose chemotherapy with hematopoietic stem-cell support in breast cancer. Bulletin du Cancer 88(9): 835-841

Montemurro, F.; Ueno, N.T.; Rondón, G.; Aglietta, M.; Champlin, R.E. 2000: High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends. Clinical Breast Cancer 1(3): 197-209; discussion 210

Crown, J.P.; Fennelly, D. 1995: High-dose chemotherapy with peripheral blood progenitor autografting. Cancer Treatment and Research 78: 209-226

Nakagawa, S.; Miki, T.; Akaza, H.; Ozono, S.; Okano, T.; Sonoda, Y.; Tsukamoto, T.; Terachi, T.; Naito, K.; Naito, S.; Nishiyama, T.; Nonomura, N.; Hara, I.; Hoshi, S.; Yoshida, O. 1999: High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group. Hinyokika Kiyo. Acta Urologica Japonica 45(11): 805-809

Mukai, H.Y.; Kojima, H.; Suzukawa, K.; Hori, M.; Komeno, T.; Hasegawa, Y.; Ninomiya, H.; Mori, N.; Nagasawa, T. 1999: High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. Leukemia and Lymphoma 32(5-6): 583-588

Miyazaki, J.; Miyanaga, N.; Kawai, K.; Shimazui, T.; Takeshima, H.; Akaza, H. 2000: High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer. International Journal of Urology: Official Journal of the Japanese Urological Association 7(7): 258-262

Nishiyama, T.; Kishi, K.; Deguchi, T.; Mukaiyama, T.; Terunuma, M. 1996: High-dose chemotherapy with peripheral blood stem-cell transplantation for hormone-refractory advanced carcinoma of the prostate: experience of two cases. International Journal of Urology: Official Journal of the Japanese Urological Association 3(4): 320-323

Huang, H.; Huang, R.; Pan, L. 2000: High-dose chemotherapy with peripheral-blood stem cells transplantation in patients with advanced gynecological malignant tumors. Zhonghua Fu Chan Ke Za Zhi 35(8): 486-489

Protheroe, A.S.; Johnson, P.W. 1996: High-dose chemotherapy with stem cell rescue for solid tumours. British Journal of Hospital Medicine 55(7): 437-441

Rodenhuis, S.; de Vries, E.G. 1999: High-dose chemotherapy with stem cell support for solid tumors in adults. Nederlands Tijdschrift Voor Geneeskunde 143(14): 731-738

Ostermann, H.; Hiddemann, W. 1999: High-dose chemotherapy with stem cell transplantation. Deutsche Medizinische Wochenschrift 124(46): 1397

McCauley, D.L. 1996: High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 53(5): 521

Mayer, J. 1997: High-dose chemotherapy--a new hope for some patients with malignant tumors?. Vnitrni Lekarstvi 43(12): 809-814

MacNeil, M.; Eisenhauer, E.A. 1999: High-dose chemotherapy: is it standard management for any common solid tumor?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(10): 1145-1161

Tayama, E.; Hayashida, N.; Fukunaga, S.; Tayama, K.; Takaseya, T.; Hiratsuka, R.; Aoyagi, S. 2001: High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass. Annals of Thoracic Surgery 72(6): 1945-1949

Di Re, F.; Bohm, S.; Oriana, S.; Spatti, G.B.; Pirovano, C.; Tedeschi, M.; Zunino, F. 1993: High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(1): 55-61

Lacava, J.A.; Ferreyra, R.; Leone, B.A.; Losada, C.; Elem, Y.L.; Vallejo, C.T. 1996: High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx. Cancer Journal from Scientific American 2(1): 46-51

Dann, E.J.; Anastasi, J.; Larson, R.A. 1998: High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(4): 1498-1504

Anonymous 1996: High-dose clarithromycin should be avoided. Aids Alert 11(9): 102

Oelzner, P.; Kunze, A.; Henzgen, S.; Thoss, K.; Hein, G.; Stein, G.; Bräuer, R. 2000: High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton. Inflammation Research: Official Journal of the European Histamine Research Society . 49(8): 424-433

Ladenstein, R.; Lasset, C.; Hartmann, O.; Garaventa, A.; Philip, T. 1993: High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. the European Group for Bone Marrow Transplantation. European Journal of Cancer 29a (11): 1632

Hartman, J. 1997: High-dose contrast media administration. Radiology 202(3): 879-880

Koudriavtseva, T.; Pozzilli, C.; Di Biasi, C.; Iannilli, M.; Trasimeni, G.; Gasperini, C.; Argentino, C.; Gualdi, G.F. 1996: High-dose contrast-enhanced MRi in multiple sclerosis. Neuroradiology 38(Suppl 1): S5-S9

Kitaichi, N.; Kotake, S.; Mizue, Y.; Sasamoto, Y.; Goda, C.; Iwabuchi, K.; Onoé, K.; Matsuda, H.; Nishihira, J. 2000: High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease. Microbiology and Immunology 44(12): 1075-1077

Payne, D. 2000: High-dose corticosteroids for asthma. Lancet 356(9239): 1444

Santini, G.; De Souza, C.; Congiu, A.M.; Nati, S.; Marino, G.; Soracco, M.; Sertoli, M.R.; Rubagotti, A.; Spriano, M.; Vassallo, F.; Rossi, E.; Vimercati, R.; Piaggio, G.; Figari, O.; Benvenuto, F.; Abate, M.; Truini, M.; Ravetti, J.L.; Ribizzi, I.; Damasio, E. 1999: High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow. Leukemia and Lymphoma 33(3-4): 321-330

Baldissera, R.C.; Aranha, J.F.P.; Oliveira, G.B.; Vigorito, A.C.; Eid, K.A.B.; Miranda, E.C.M.; De Souza, C.A. 2002: High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma. Brazilian Journal of Medical and Biological Research 35(1): 49-57

Brodsky, R.A.; Jones, R.J. 2001: High-dose cyclophosphamide in aplastic anaemia. Lancet 357(9262): 1128-1129

Jaime-Pérez, J.C.; González-Llano, O.; Gómez-Almaguer, D. 2001: High-dose cyclophosphamide in the treatment of severe aplastic anemia in children. American Journal of Hematology 66(1): 71

Selvam, A. 2001: The state of the health care workforce. Hospitals and Health Networks 75(8): 41; 43-48

Bingham, S.; Veale, D.; Fearon, U.; Isaacs, J.D.; Morgan, G.; Emery, P.; McGonagle, D.; Reece, R.; Clague, R.; Snowden, J.A. 2002: High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis and Rheumatism 46(3): 837-839

Petri, M.; Jones, R.J.; Brodsky, R.A. 2003: High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis and Rheumatism 48(1): 166-173

Wheeler, C.; Eickhoff, C.; Elias, A.; Ibrahim, J.; Ayash, L.; McCauley, M.; Mauch, P.; Schwartz, G.; Eder, J.P.; Mazanet, R.; Ferrara, J.; Rimm, I.J.; Guinan, E.; Bierer, B.; Gilliland, G.; Churchill, W.H.; Ault, K.; Parsons, S.; Antman, K.; Schnipper, L.; Tepler, I.; Gaynes, L.; Frei, E.; Kadin, M.; Antin, J. 1997: High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 3(2): 98-106

Bisogno, G.; Cowie, F.; Boddy, A.; Thomas, H.D.; Dick, G.; Pinkerton, C.R. 1998: High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours. British Journal of Cancer 77(12): 2304-2309

Wang, W.S.; Tzeng, C.H.; Chiou, T.J.; Liu, J.H.; Fan, S.; Chen, P.M. 1996: High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Zhonghua Yi Xue Za Zhi 57(2): 100-105

Schiller, G.; Emmanoulides, C.; Iastrebner, M.C.; Lee, M.; Naeim, F. 1996: High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia. Leukemia and Lymphoma 20(5-6): 427-434

Shepherd, J.D.; Barnett, M.J.; Philips, G.L. 1996: High-dose cytarabine induction for acute myeloid leukemia. Blood 88(2): 754-755

Mercadante, S.; Fulfaro, F. 1999: Alternatives to oral opioids for cancer pain. Oncology 13(2): 215

Robertson, L.E.; Hall, R.; Keating, M.J.; Estey, E.; Kantarjian, H.M.; McLaughlin, P.; Hagemeister, F.B.; Plunkett, W. 1993: High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis. Leukemia and Lymphoma 10(1-2): 43-48

Cetkovská, P.; Pizinger, K.; Cetkovský, P. 2002: High-dose cytosine arabinoside-induced cutaneous reactions. Journal of the European Academy of Dermatology and Venereology: Jeadv 16(5): 481-485

Douglas, J.T.; Shaw, J. 1997: High-dose desmopressin in bleeding disorders. European Journal of Anaesthesiology. Supplement 14: v-vi

Sadikot, R.T.; Jansen, E.D.; Blackwell, T.R.; Zoia, O.; Yull, F.; Christman, J.W.; Blackwell, T.S. 2001: High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. American Journal of Respiratory and Critical Care Medicine 164(5): 873-878

Chandra, J. 1997: High-dose dexamethasone for chronic/refractory immune thrombocytopenia. Indian Pediatrics 34(6): 565-566

Schiavotto, C.; Ruggeri, M.; Castaman, G.; Rodeghiero, F. 1996: High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura. British Journal of Haematology 93(2): 491-492

Molica, S. 1994: High-dose dexamethasone in refractory B-cell chronic lymphocytic leukemia patients. American Journal of Hematology 47(4): 334

Godeau, B.; Bierling, P.; Oksenhendler, E.; Castaigne, S.; Deconinck, E.; Wechsler, B. 1996: High-dose dexamethasone therapy for resistant autoimmune thrombocytopenic purpura. American Journal of Hematology 51(4): 334

Hollander, D.; Pradas, J.; Kaplan, R.; McLeod, H.L.; Evans, W.E.; Munsat, T.L. 1994: High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies. Annals of Neurology 36(6): 920-924

Kosty, M.P.; Herndon, J.E.; Vogelzang, N.J.; Kindler, H.L.; Green, M.R. 2001: High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase Ii study-Cancer and Leukemia Group B 9631. Lung Cancer 34(2): 289-295

Bertha, B.G.; Sill, J.C.; Berger, I.; Folts, J.D.; Milde, J.H. 1993: High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets. Anesthesiology 78(4): 733-743

Pisters, K.M.; Tyson, L.B.; Tong, W.; Fleisher, M.; Miller, V.A.; Grant, S.C.; Pfister, D.G.; Rigas, J.R.; Densmore, C.L.; Krol, G.; Heelan, R.T.; Sirotnak, F.M.; Bertino, J.R.; Kris, M.G. 1996: High-dose edatrexate with oral leucovorin rescue: a phase i and clinical pharmacological study in adults with advanced cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(11): 1819-1824

Escobar Sacristán, J.; de Granda Orive, J.I.; Gutiérrez Jiménez, T.; Martínez Albiach, J.M.; Fuentes Ramos, M.; Herrera de la Rosa, A. 1997: High-dose endobronchial brachytherapy in malignant tumors of the lung. Archivos de Bronconeumologia 33(6): 278-283

Manfredi, P.L.; Chandler, S.W.; Patt, R.; Payne, R. 1997: High-dose epidural infusion of opioids for cancer pain: cost issues. Journal of Pain and Symptom Management 13(2): 118-121

Karch, S.B. 1993: High-dose epinephrine. American Journal of Emergency Medicine 11(4): 423-426

Mattana, J.; Singhal, P.C. 1993: High-dose epinephrine in cardiopulmonary resuscitation. New England Journal of Medicine 328(10): 735; Author Reply 735-736

Frank, S.E. 1994: High-dose epinephrine in cardiopulmonary resuscitation: are we missing the question?. Critical Care Medicine 22(12): 2030-2031

Onat, H.; Basaran, M.; Esassolak, M.; Bavbek, S.E.; Anacak, Y.; Kaytan, E.; Altun, M.; Haydaroglu, A. 2002: High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma. Clinical Oncology 14(6): 449-454

Cottu, P.H.; Zelek, L.; Extra, J.M.; Espie, M.; Mignot, L.; Morvan, F.; Marty, M. 1999: High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(7): 795-801

Kamata, K.; Sato, N.; Takahashi, E. 1993: High-dose erythropoietin for unstable hemoglobin Burke in a patient receiving hemodialysis. New England Journal of Medicine 328(20): 1498-1499

Pivalizza, E.G.; Sweeney, M.S. 1997: High-dose esmolol and cardiopulmonary bypass for mitral valve replacement in the beating heart. Journal of Cardiothoracic and Vascular Anesthesia 11(4): 485-486

Pucci, G.; Irrera, G.; Martino, M.; Messina, G.; Console, G.; Morabito, F.; Iacopino, P. 1998: High-dose etoposide enables the collection of peripheral blood stem cells in patients who failed cyclophosphamide-induced mobilization. British Journal of Haematology 100(3): 612-613

Kohara, H.; Ueoka, H.; Tabata, M.; Shinagawa, K.; Hayashi, K.; Harada, M. 1997: High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast. Internal Medicine 36(10): 738-741

Brown, R.A.; Wolff, S.N.; Fay, J.W.; Pineiro, L.; Collins, R.H.; Lynch, J.P.; Stevens, D.; Greer, J.; Herzig, R.H.; Herzig, G.P. 1996: High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leukemia and Lymphoma 22(3-4): 271-277

Graham, D.Y. 1997: High-dose famotidine for prevention of NSAID ulcers?. Gastroenterology 112(6): 2143-2145

Morimoto, Y.; Morimoto, Y.; Bart, R.D.; Pearlstein, R.D.; Dexter, F.; Warner, D.S. 1997: High-dose fentanyl does not adversely affect outcome from forebrain ischemia in the rat. Journal of Neurosurgical Anesthesiology 9(4): 316-323

Numai, T.; Inaba, H.; Mizuguchi, T. 1996: High-dose fentanyl does not suppress interleukin-1 beta-induced increases in plasma ACTH and corticosterone in rats. Acta Anaesthesiologica Scandinavica 40(2): 143-150

Haubrich, R.H.; Haghighat, D.; Bozzette, S.A.; Tilles, J.; McCutchan, J.A. 1994: High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. the California Collaborative Treatment Group. Journal of Infectious Diseases 170(1): 238-242

Archer, B.R. 2002: High-dose fluoroscopy: the administrator's responsibilities. Radiology Management 24(2): 26-32; Quiz: 33-35

Ruiz, Mín.; Vairo, C.; Matusevich, D.; Finkelsztein, C. 2002: High-dose fluoxetine-induced mania. Review and case report. Vertex 13(48): 93-97

Mustacchi, G.; Pavesi, L.; Milani, S.; Iaffaioli, V.; Caraco, A.; Comella, G.; Contu, A.; Farris, A.; Attado-Parinello, G.; Narcisi, M. 1994: High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial. Anticancer Research 14(2b): 617-619

Di Costanzo, F.; Gasperoni, S.; Malacarne, P.; Belsanti, V.; Luppi, G.; Marzola, M.; Corgna, E.; Sdrobolini, A.; Passalacqua, R.; Figoli, F.; Algeri, R.; Zironi, S.; Angiona, S.; Boni, C. 1998: High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research. American Journal of Clinical Oncology 21(4): 369-375

Louvet, C.; Beerblock, K.; de Gramont, A.; Varette, C.; Demuynck, B.; Bennamoun, M.; Cady, J.; Delfau, S.; Maisani, J.E.; Krulik, M. 1993: High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study. European Journal of Cancer 29a (8): 1217

Waugh, J.B.; Op't Holt, T.B.; Gadek, J.E.; Clanton, T.L. 1996: High-dose furosemide alters gas exchange in a model of acute lung injury. Journal of Critical Care 11(3): 129-137

Lévy, P.; Perniceni, T.; Gayet, B. 1997: High-dose furosemide: a new cause of chronic pancreatitis?. Gastroenterologie Clinique et Biologique 21(12): 1004-1005

Kallmes, D.F.; Gray, L.; Glass, J.P. 1998: High-dose gadolinium-enhanced MRi for diagnosis of meningeal metastases. Neuroradiology 40(1): 23-26

Juneja, S.K.; Phillips, K.A.; Speed, B.; Januszewicz, E.H. 1996: High-dose gamma-globulin responsive haemolysis due to cytomegalovirus in an immunocompetent adult. British Journal of Haematology 95(2): 433-435

Bain, S.D.; Jensen, E.; Celino, D.L.; Bailey, M.C.; Lantry, M.M.; Edwards, M.W. 1993: High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 8(2): 219-230

Aasen, A.O.; Svennevig, J.L. 1993: High-dose glucocorticoids in surgery and trauma. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(4): 437-438

Yokoya, S.; Araki, K.; Igarashi, Y.; Kohno, H.; Nishi, Y.; Hasegawa, Y.; Fujita, K.; Iwatani, N.; Tachibana, K.; Ohyama, Y.; Seino, Y.; Satoh, M.; Fujieda, K.; Tanaka, T. 1999: High-dose growth hormone (GH) treatment in prepubertal GH-deficient children. Acta Paediatrica . Suppl 88(428): 76-79

De Zegher, F.; Maes, M.; Heinrichs, C.; Thiry, G.; Du Caju, M.V.; De Schepper, J.; Craen, M.; Chanoine, J.P.; Dooms, L.; Malvaux, P. 1994: High-dose growth hormone therapy for short children born small for gestational age. Belgian Study Group for Paediatric Endocrinology. Acta Paediatrica . Suppl 399(77): Discussion 78

Cipri, S.; Gangemi, A.; Campolo, C.; Cafarelli, F.; Gambardella, G. 1998: High-dose heparin plus warfarin administration in non-traumatic dural sinuses thrombosis. a clinical and neuroradiological study. Journal of Neurosurgical Sciences 42(1): 23-32

Porta, C.; Bobbio-Pallavicini, E. 1994: High-dose human immunoglobulins in thrombotic thrombocytopenic purpura. American Journal of Hematology 45(1): 99-100

Mehta, J.; Powles, R.; Singhal, S.; Swansbury, G.J.; Millar, B.; Shepherd, V.; Bell, J.; Min, T.; Cabral, S.; Treleaven, J. 1996: High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results. Leukemia and Lymphoma 23(1-2): 107-111

Petzer, A.L.; Hochenburger, E.; Haun, M.; Duba, H.C.; Grünewald, K.; Hoflehner, E.; Sill, H.; Linkesch, W.; Gastl, G.ün.; Gunsilius, E. 2002: High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration. Journal of HematoTherapy and Stem Cell Research 11(2): 293-300

Pascual, J.; Cid, C.; Berciano, J. 1998: High-dose I.v. immunoglobulin for peripheral neuropathy associated with Sjögren's syndrome. Neurology 51(2): 650-651

Verweij, J. 1998: High-dose ifosfamide for soft tissue sarcomas: set the scene, or senescence?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(8): 807-809

Patel, S.R.; Vadhan-Raj, S.; Papadopolous, N.; Plager, C.; Burgess, M.A.; Hays, C.; Benjamin, R.S. 1997: High-dose ifosfamide in bone and soft tissue sarcomas: results of phase Ii and pilot studies--dose-response and schedule dependence. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(6): 2378-2384

Vergnenègre, A.; Thomas, P.; Robinet, G.; Pibarot, M.; Paillotin, D.; Vernejoux, J.M.; Thiberville, L.; Lena, H.; Kleisbauer, J.P.; Gimonet, J.F. 1999: High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase Ii trial from the Groupe français de pneumo-cancérologie (GFPC). Bulletin du Cancer 86(12): 1017-1021

Tursz, T. 1996: High-dose ifosfamide in the treatment of advanced soft tissue sarcomas. Seminars in Oncology 23(3 Suppl 7: 34-39

Tiuliandin, S.A.; Liubimova, N.V.; Sidorova, N.I.; Averinova, S.G.; Kashkadaeva, A.V.; Romanova, L.F.; Shiriaev, S.V.; Garin, A.M. 1996: High-dose ifosfamide in the treatment of patients with soft tissue sarcoma. Voprosy Onkologii 42(6): 19-22

De Pas, T.; De Braud, F.; Orlando, L.; Nolè, F.; Munzone, E.; Zampino, M.G.; Fazio, N.; Aapro, M.S.; Goldhirsch, A. 1998: High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(8): 917-919

Patel, S.R.; Forman, A.D.; Benjamin, R.S. 1994: High-dose ifosfamide-induced exacerbation of peripheral neuropathy. Journal of the National Cancer Institute 86(4): 305-306

Burt, R.K.; Traynor, A.; Oyama, Y.; Craig, R. 2003: High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 101(5): 2064-2066

Rostoker, G.; Desvaux-Belghiti, D.; Pilatte, Y.; Petit-Phar, M.; Philippon, C.; Deforges, L.; Terzidis, H.; Intrator, L.; André, C.; Adnot, S.; Bonin, P.; Bierling, P.; Remy, P.; Lagrue, G.; Lang, P.; Weil, B. 1994: High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Annals of Internal Medicine 120(6): 476-484

Bodenstein, H. 1993: High-dose immunoglobulin therapy of aplastic syndrome. Infusionstherapie und Transfusionsmedizin 20(Suppl 1): 99

Voit, T. 1993: High-dose immunoglobulin treatment of epilepsy in children. Infusionstherapie und Transfusionsmedizin 20(Suppl 1): 146-148; Discussion 149

Openshaw, H.; Nash, R.A.; McSweeney, P.A. 2002: High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 8(5): 233-248

McSweeney, P.A.; Furst, D.E.; West, S.G. 1999: High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions. Arthritis and Rheumatism 42(11): 2269-2274

Heckmann, J.M.; LeePan, E.B.; Eastman, R.W. 2001: High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up study. South African Medical Journal 91(9): 765-770

Wils, J.A. 1996: High-dose infusional 5-FU in the treatment of advanced colorectal cancer: a summary of the European experience. Journal of Infusional ChemoTherapy 6(3): 145-148

Loeffler, T.M.; Hausamen, T.U. 1996: High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer. Journal of Infusional ChemoTherapy 6(3): 137-140

Morgan, R.J.; Doroshow, J.H.; Venkataraman, K.; Chang, K.; Raschko, J.; Somlo, G.; Leong, L.; Tetef, M.; Shibata, S.; Hamasaki, V.; Margolin, K.; Forman, S.; Akman, S.; Coluzzi, P.; Ahn, C.; Weiss, L.; Gadgil, U.; Harrison, J. 1997: High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(12 Part 1): 2337-2345

Zhang, M.; Nishimura, K.; Ikeda, A.; Tsukino, M.; Koyama, H.; Izumi, T. 1995: High-dose inhaled beclomethasone dipropionate and maximal improvements in patients with stable chronic obstructive pulmonary disease. Nihon Kyobu Shikkan Gakkai Zasshi 33(12): 1386-1391

Kudo, K.; Tanabe, N.; Kabe, J. 1996: High-dose inhaled beclomethasone in long-term management of chronic severe asthma--usefulness and dose-dependence. Nihon Kyobu Shikkan Gakkai Zasshi 34(5): 536-544

Lenney, W. 1996: High-dose inhaled steroids in asthmatic children. Lancet 348(9030): 819-820

Lipworth, B.J.; Clark, D. 1996: High-dose inhaled steroids in asthmatic children. Lancet 348(9030): 820; author reply 821

Watson, A.R.; Bartlomé, P. 1994: High-dose interferon alfa-2A for the treatment of chronic hepatitis C. Annals of PharmacoTherapy 28(3): 341-342

Fontana, R.J.; Walsh, J.; Moyer, C.A.; Lok, A.S.F.; Webster, S.; Klein, S. 2002: High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial. Journal of Clinical Gastroenterology 34(2): 177-182

Bresci, G.; Parisi, G.; Bertoni, M.; Capria, A. 2000: High-dose interferon plus ribavirin in chronic hepatitis C not responding to recombinant alpha-interferon. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 32(8): 703-707

Bonkovsky, H.L.; Clifford, B.D.; Smith, L.J.; Allan, C.; Banner, B. 1996: High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. a controlled randomized trial. Digestive Diseases and Sciences 41(1): 149-154

Saiag, P. 1999: High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?. Annales de Dermatologie et de Venereologie 126(3): 211-213

Dutcher, J. 2002: High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma. Oncology 16(11 Suppl 13: 3

Wilson, W.R.; Siegel, R.S.; Harisiadis, L.A.; Davis, D.O.; Nguyen, H.H.; Bank, W.O. 2001: High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Archives of Otolaryngology--Head and Neck Surgery 127(7): 809-812

Twardowski, Z.J. 1998: High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 31(5): 841-847

Mitterhofer, A.P.; Antonelli, M.; Genuini, I.; Bertazzoni, G. 1998: High-dose intranasal snorted heroin: a new cause of pancreatitis. Pancreas 17(2): 213-215

Stacey, R.; Jones, R.; Kar, G.; Poon, A. 2001: High-dose intrathecal diamorphine for analgesia after Caesarean section. Anaesthesia 56(1): 54-60

Chaney, M.A. 1996: High-dose intrathecal morphine for thoracoabdominal aneurysm repair. Journal of Cardiothoracic and Vascular Anesthesia 10(2): 306-307

Tamakawa, S.; Iwanami, Y.; Ogawa, H. 1998: High-dose intrathecal morphine to control cancer pain--a case report. Journal of Pain and Symptom Management 15(1): 70-72

Dill, C.; Shin, S. 2000: High-dose intravenous benzodiazepine. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 7(3): 308-310

Hermida-Rodriguez, C.; Cantero Perona, J.; Garcia-Valriberas, R.; Pajares Garcia, J.M.; Mate-Jimenez, J. 1999: High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease. Hepato-Gastroenterology 46(28): 2265-2268

Honda, M.; Umeda, H.; Yoshida, K. 1998: High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 2145-2149

Moriguchi, H.; Yoshida, K.; Kitahara, S. 2000: High-dose intravenous estrogen therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 330-334

Sensky, P.R.; Olczak, S.A. 1999: High-dose intravenous glucagon in severe tricyclic poisoning. Postgraduate Medical Journal 75(888): 611-612

Schneider, P.; Wehmeier, A.; Schneider, W. 1997: High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. New England Journal of Medicine 337(15): 1087-1088; Author Reply 1089

Sudo, K.; Tajima, Y.; Matsumoto, A. 2002: High-dose intravenous immune globulin for stiff-person syndrome. New England Journal of Medicine 346(22): 1747-1748; Author Reply 1747-1748

Jolles, S. 2002: High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders. Clinical and Experimental Immunology 129(3): 385-389

Nobile-Orazio, E.; Meucci, N. 1999: High-dose intravenous immunoglobulin in multifocal motor neuropathy. Electroencephalography and Clinical Neurophysiology. Suppl 50: 506-513

Bassan, H.; Muhlbaur, B.; Tomer, A.; Spirer, Z. 1998: High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis. Pediatric Neurology 18(2): 181-183

Puppo, F. 2002: High-dose intravenous immunoglobulin therapy for immune-mediated disorders. only immunoglobulins?. Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 17(1): 9-10

Selcen, D.; Dabrowski, E.R.; Michon, A.M.; Nigro, M.A. 2000: High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatric Neurology 22(1): 40-43

Rauova, L.; Lukac, J.; Levy, Y.; Rovensky, J.; Shoenfeld, Y. 2001: High-dose intravenous immunoglobulins for lupus nephritis--a salvage immunomodulation. Lupus 10(3): 209-213

Rütter, A.; Luger, T.A. 2001: High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. Journal of the American Academy of Dermatology 44(6): 1010-1024

Woodhouse, D. 1993: High-dose intravenous infusions of Solu-Medrol for use in acute spinal cord injuries. Medical Journal of Australia 159(1): 70-71

Labar, D.R.; Ali, A.; Root, J. 1994: High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 44(8): 1400-1403

Griffin, T.C.; McIntire, D.; Buchanan, G.R. 1994: High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. New England Journal of Medicine 330(11): 733-737

Reed, J.B.; Morse, L.S.; Schwab, I.R. 1998: High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis. American Journal of Ophthalmology 125(3): 409-411

Seppel, T.; Schlaghecke, R.; Becker, A.; Engelbrecht, V.; Feldkamp, J.; Kornely, E. 1996: High-dose intravenous therapy with 7S immunoglobulins in autoimmune endocrine ophthalmopathy. Clinical and Experimental Rheumatology 14(Suppl 15): S109-S114

Cochereau, I.; Diraison, M.C.; Mousalatti, H.; Bouyer, I.; Ren, L.; Guvenisik, N.; Hoang-Xuan, T. 2000: High-dose intravitreal ganciclovir in CMV retinitis. Journal Francais d'Ophtalmologie 23(2): 123-126

Chen, M.-S.; Li, J.-Q.; Zhang, Y.-Q.; Lu, L.-X.; Zhang, W.-Z.; Yuan, Y.-F.; Guo, Y.-P.; Lin, X.-J.; Li, G.-H. 2002: High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World Journal of Gastroenterology 8(1): 74-78

Tarumi, Y.; Watanabe, S.; Bruera, E.; Ishitani, K. 2000: High-dose ketamine in the management of cancer-related neuropathic pain. Journal of Pain and Symptom Management 19(6): 405-407

Cascinu, S.; Bichisao, E.; Amadori, D.; Silingardi, V.; Giordani, P.; Sansoni, E.; Luppi, G.; Catalano, V.; Agostinelli, R.; Catalano, G. 2000: High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 8(1): 65-67

Aksu, F.; Madazli, R.; Budak, E.; Cepni, I.; Benian, A. 1997: High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents. Australian and New Zealand Journal of Obstetrics and Gynaecology 37(2): 228-231

Popov, I.; Jelić, S.; Milanović, N.; Kovcin, V.; Vuletić, L. 1996: High-dose medroxyprogesterone acetate in the treatment of metastatic carcinoma of renal parenchyma. Srpski Arhiv Za Celokupno Lekarstvo 124(3-4): 73-76

Moreau, P.; Milpied, N.; de Faucal, P.; Petit, T.; Herbouiller, P.; Bataille, R.; Harousseau, J.L. 1996: High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement. Blood 87(7): 3063-3064

Moreau, P.; Bataille, R.; Mahé, B.; Milpied, N.; Harousseau, J.L. 1993: High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(9): 1832

Rives, S.; Bladé, J.; Martínez, C.; Marín, P.; Carreras, E.; Montserrat, E. 2000: High-dose melphalan treatment followed by hematopoietic progenitor cell rescue in primary amyloidosis. Medicina Clinica 115(6): 216-220

Hjorth, M.; Lenhoff, S.; Turesson, I.; Westin, J. 2000: High-dose melphalan with stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective. Lakartidningen 97(41): 4585-4586; 4589-4592

Philip, T.; Iliescu, C.; Demaille, M.C.; Pacquement, H.; Gentet, J.C.; Krakowski, I.; Soler-Michel, P.; Thiesse, P.; Chauvin, F.; Blay, J.Y.; Brunat-Mentigny, M. 1999: High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(9): 1065-1071

Brain, E.; Alexandre, J.; Minozzi, C.; Misset, J.L. 1997: High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis. Presse Medicale 26(6): 265-268

Shamash, J.; Joel, S.; Lundholm, L.; Millard, L.; Oliver, T. 2003: High-dose methotrexate clearance following prior vancomycin administration: no significant interaction in the absence of overt renal impairment. Annals of Oncology: Official Journal of the European Society for Medical Oncology 14(1): 169-170

Batchelor, T.; Leahy, N.; Kaufman, D. 2001: High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma. Clinical Lymphoma 2(2): 116-119; Discussion: 120-122

Ng, S.; Rosenthal, M.A.; Ashley, D.; Cher, L. 2000: High-dose methotrexate for primary CNS lymphoma in the elderly. Neuro-Oncology 2(1): 40-44

Chowbay, B.; Siong, K.K. 2001: High-dose methotrexate in fibroblastic osteosarcoma. Annals of PharmacoTherapy 35(12): 1669

Cole, P.D.; Kamen, B.A. 2000: High-dose methotrexate is lethal to rats. Why give it to children?. Pediatric Hematology and Oncology 17(8): 609-613

Kamen, B.A.; Weitman, S.D. 1994: High-dose methotrexate: is it warranted?. Pediatric Hematology and Oncology 11(2): 135-137

Chakrabarti, S.; Behera, D.; Varma, S.; Bambery, P. 1997: High-dose methyl prednisolone for autoimmune thrombocytopenia in sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 14(2): 188

Nayduch, D.; Lee, A.; Butler, D. 1994: High-dose methylprednisolone after acute spinal cord injury. Critical Care Nurse 14(4): 69-72; 77-78

Gurgey, A.; Sayli, T.; Gunay, M.; Ersoy, F.; Kucukali, T.; Kale, G.; Caglar, M. 1994: High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement. American Journal of Hematology 47(4): 331-332

Hugenholtz, H.; Cass, D.E.; Dvorak, M.F.; Fewer, D.H.; Fox, R.J.; Izukawa, D.M.S.; Lexchin, J.; Tuli, S.; Bharatwal, N.; Short, C. 2002: High-dose methylprednisolone for acute closed spinal cord injury--only a treatment option. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 29(3): 227-235

Hi[csönmez, G.; Ozsoylu, S.; Onat, N.; Prozorova, Z.V.; Gümrük, F.; Tuncer, M. 1994: High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia. Medical and Pediatric Oncology 22(1): 68-69

Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up. Acta Neurologica 15(1): 33-43

Pettersson, K.; Toolanen, G. 1998: High-dose methylprednisolone prevents extensive sick leave after whiplash injury. A prospective, randomized, double-blind study. Spine 23(9): 984-989

Kurata, H.; Yamazaki, I.; Ishii, M.; Yano, Y.; Kase, M.; Tomiyama, I. 1997: High-dose methylprednisolone pulse therapy for respiratory failure after open heart surgery. Kyobu Geka. Japanese Journal of Thoracic Surgery 50(4): 292-297

Dufour, A.; Salmaggi, A.; La Mantia, L.; Eoli, M.; Nespolo, A.; Milanese, C. 1994: High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. International Journal of Neuroscience 75(1-2): 119-128

Suda, T.; Sugimura, S.; Hattori, Y.; Sugimura, H.; Kobayashi, Y.; Hoshino, R. 1998: High-dose methylprednisolone-containing chemotherapy in advanced invasive thymoma--report of three cases. Japanese Journal of Thoracic and Cardiovascular Surgery: Official Publication of the Japanese Association for Thoracic Surgery 46(1): 115-120

Yetgin, S.; Ozbek, N. 1997: High-dose methylprednisolone-induced dramatic maturation of granulocytes in idiopathic chronic neutropenia. Turkish Journal of Pediatrics 39(2): 259-263

Oldhafer, K.J.; Frerker, M.K.; Lang, H.; Fauler, J.; Flemming, P.; Schmoll, E.; Nadalin, S.; Moreno, L.; Pichlmayr, R. 1998: High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastases. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 11(6): 393-400

Feldman, E.J. 1997: High-dose mitoxantrone in acute leukaemia: New York Medical College experience. European journal of cancer care 6(4 Suppl): 27-32

Grevelhörster, T.; Micke, O.; Hampel, G.; Schönekaes, K.; Willich, N. 1996: High-dose multimodal radiotherapy of confluent destructively growing aggregated keratoacanthoma. 2 case reports. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 172(7): 395-400

Marrazzi, M.A.; Wroblewski, J.M.; Kinzie, J.; Luby, E.D. 1997: High-dose naltrexone and liver function safety. American Journal on Addictions 6(1): 21-29

Schumann, R.E.; Swindle, M.M.; Knick, B.J.; Case, C.L.; Gillette, P.C. 1994: High-dose narcotic anesthesia using sufentanil in swine for cardiac catheterization and electrophysiologic studies. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 7(3): 243-248

Komatsu, M.; Suto, T.; Ishikawa, K.; Sato, S. 1999: High-dose natural interferon-alpha therapy for chronic hepatitis C with a high viral load: predictors of efficacy. the Aomori, Akita and Iwate Areas Viral Hepatitis Research Group. Journal of Gastroenterology and Hepatology 14(7): 675-681

Fleishman, M. 1994: High-dose neuroleptics. Hospital and Community Psychiatry 45(7): 721-722

Guglina, M.E. 1997: High-dose nitroglycerin in cardiogenic shock. Klinicheskaia Meditsina 75(6): 27-30

Sheitman, B.B.; Lindgren, J.C.; Early, J.; Sved, M. 1997: High-dose olanzapine for treatment-refractory schizophrenia. American Journal of Psychiatry 154(11): 1626

Heimann, S.W. 1999: High-dose olanzapine in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry 38(5): 496-498

Van Biervliet, S.; Van Winckel, M.; Robberecht, E.; Kerremans, I. 2001: High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia. Journal of Pediatric Surgery 36(9): 1416-1418

Friedel, D.; Ozick, L.A. 1999: High-dose omeprazole in patients with noncardiac chest pain. Gastroenterology 116(1): 226-227

Busam, J.; Garbe, W.E. 1994: High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison. Zeitschrift für Gastroenterologie 32(2): 94-99

Paice, J.A. 2002: High-dose opioids may manage neuropathic pain. Oncology Nursing Forum 29(6): 900

Korones, D.N. 1996: High-dose oral dexamethasone therapy in idiopathic thrombocytopenic purpura. Journal of Pediatrics 129(5): 772-773

Castagnola, E.; Cristina, E.; Dufour, C. 2002: High-dose oral ganciclovir for management of CMV-symptomatic infection in a child with acute lymphoblastic leukemia. Medical and Pediatric Oncology 38(4): 295-296

Ramin, K.D.; Ogburn, P.L.; Danilenko, D.R.; Ramsey, P.S. 2002: High-dose oral misoprostol for mid-trimester pregnancy interruption. Gynecologic and Obstetric Investigation 54(3): 176-179

Radbruch, L.; Grond, S.; Zech, D.J.; Bischoff, A. 1996: High-dose oral morphine in cancer pain management: a report of twelve cases. Journal of Clinical Anesthesia 8(2): 144-150

Dombrowski, M.P.; Bottoms, S.F. 1996: High-dose oxytocin. American Journal of Obstetrics and Gynecology 175(1): 240

Vogelzang, N.J.; Herndon, J.E.; Miller, A.; Strauss, G.; Clamon, G.; Stewart, F.M.; Aisner, J.; Lyss, A.; Cooper, M.R.; Suzuki, Y.; Green, M.R. 1999: High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase Ii study 9234. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(5): 597-600

Elgindy, N.; Lindholm, H.; Gunvén, P. 2000: High-dose percutaneous ethanol injection therapy of liver tumors. Patient acceptance and complications. Acta Radiologica 41(5): 458-463

Facca, A.; Sanchez-Ramos, J. 1996: High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Movement Disorders: Official Journal of the Movement Disorder Society 11(3): 327-329

Trivedi, H.L.; Shah, V.R.; Vanikar, A.V.; Gera, D.; Shah, P.R.; Trivedi, V.B.; Khemchandani, S.; Mehta, A.; Dalal, S.S.; Shah, S.A.; Shah, T.P.; Visana, K.V. 2002: High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients. Pediatric Transplantation 6(1): 63-68

Maltoni, M.; Nanni, O.; Scarpi, E.; Rossi, D.; Serra, P.; Amadori, D. 2001: High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(3): 289-300

Friedli, A.; Salomon, D.; Saurat, J.H. 2001: High-dose pulse corticosteroid therapy: is it indicated for severe alopecia areata?. Dermatology 202(3): 191-192

Demiroğlu, H.; Dündar, S. 1997: High-dose pulsed dexamethasone for immune thrombocytopenia. New England Journal of Medicine 337(6): 425-427

Willers, H.; Würschmidt, F.; Bünemann, H.; Heilmann, H.P. 1998: High-dose radiation therapy alone for inoperable non-small cell lung cancer--experience with prolonged overall treatment times. Acta Oncologica 37(1): 101-105

Peiffert, D.; Giovannini, M.; Ducreux, M.; Michel, P.; François, E.; Lemanski, C.; Mirabel, X.; Cvitkovic, F.; Luporsi, E.; Conroy, T.; Gérard, J.P. 2001: High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase Ii study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(3): 397-404

Hayakawa, K.; Mitsuhashi, N.; Katano, S.; Saito, Y.; Nakayama, Y.; Sakurai, H.; Akimoto, T.; Hasegawa, M.; Yamakawa, M.; Niibe, H. 2001: High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32(1): 81-88

Press, O.W.; Eary, J.; Badger, C.C.; Appelbaum, F.R.; Wiseman, G.; Matthews, D.; Martin, P.J.; Bernstein, I.D. 1993: High-dose radioimmunotherapy of lymphomas. Cancer Treatment and Research 68: 13-22

Cetin, L.; Yilmaz, E.; Alpsoy, E.; Başaran, E. 1997: High-dose ranitidine is ineffective in the treatment of psoriasis. British Journal of Dermatology 137(6): 1021-1022

Inoue, K.; Kasahara, K.; Karashima, T.; Inoue, Y.; Kariya, S.; Inomata, T.; Yoshida, S.; Shuin, T. 2001: High-dose rate Iridium-192 brachytherapy with flexible applicator--a trial toward decrease of stress during treatment and improvement of quality of life. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 92(5): 566-571

Muto, P.; Ravo, V.; Panelli, G.; Liguori, G.; Fraioli, G. 2000: High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy. Oncologist 5(3): 209-214

Böhmer, D.; Deger, S.; Dinges, S.; Schnorr, D.; Loening, S.A.; Budach, V. 2002: High-dose rate brachytherapy--the Charité experience. Frontiers of Radiation Therapy and Oncology 36: 177-182

Taulelle, M.; Chauvet, B.; Vincent, P.; Félix-Faure, C.; Bucciarelli, B.; Garcia, R.; Reboul, F. 1996: High-dose rate endobronchial brachytherapy: results and complications in 189 patients. Bulletin du Cancer. Radiotherapie: Journal de la Societe Francaise du Cancer: Organe de la Societe Francaise de Radiotherapie Oncologique 83(3): 127-134

Inoue, T.; Inoue, T. 2000: High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase IIi trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 291-295

Inoue, T.; Inoue, T.; Yoshioka, Y.; Yoshida, K. 2000: High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 296-300

Teshima, T.; Inoue, T.; Inoue, T.; Ikeda, H.; Sasaki, S.; Yamazaki, H.; Ohtani, M.; Murayama, S.; Kozuka, T. 1993: High-dose rate intracavitary therapy for cervical cancer with a microSelectron: a preliminary report. Radiation Medicine 11(6): 237-241

Merchant, T.E.; Zelefsky, M.J.; Sheldon, J.M.; LaQuaglia, M.B.; Harrison, L.B. 1998: High-dose rate intraoperative radiation therapy for pediatric solid tumors. Medical and Pediatric Oncology 30(1): 34-39

Kasahara, K.; Inoue, K.; Karashima, T.; Inoue, Y.; Kariya, S.; Inomata, T.; Yoshida, S.; Shuin, T. 2001: High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 92(5): 572-578

Deger, S.; Dinges, S.; Roigas, J.; Schnorr, D.; Turk, I.; Budach, V.; Hinkelbein, W.; Loening, S.A. 1997: High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer. Techniques in Urology 3(4): 190-194

Tagliaferri, P.; Correale, P.; Mottola, M.; de Simone, G.; Montesarchio, V.; Matano, E.; Rea, A.; Morabito, A.; Famiani, M.; Ciardiello, F.; Tortora, G.; Caraglia, M.; Barile, C.; Palmieri, G.; Bianco, A.R. 1996: High-dose recombinant interleukin-2/verapamil combination in advanced cancer. European Journal of Cancer 32a (8): 1436-1437

Mattimoe, D.; Newton, W. 1998: High-dose riboflavin for migraine prophylaxis. Journal of Family Practice 47(1): 11

Kellner, C.H. 2000: High-dose right unilateral ECT. Journal of Ect 16(3): 209-210

Keating, M.; O'Brien, S. 2000: High-dose rituximab therapy in chronic lymphocytic leukemia. Seminars in Oncology 27(6 Suppl 12: 86-90

Franzius, C.; Schuck, A.; Bielack, S.S. 2002: High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(7): 1953-1954

Paredes, R.; Puig, T.; Arnó, A.; Negredo, E.; Balagué, M.; Bonjoch, A.; Jou, A.; Tuldrà, A.; Tural, C.; Sirera, G.; Veny, A.; Romeu, J.; Ruiz, L.; Clotet, B. 1999: High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response. Journal of Acquired Immune Deficiency Syndromes 22(2): 132-138

Tarella, C.; Cuttica, A.; Caracciolo, D.; Zallio, F.; Ricca, I.; Bergui, L.; Gavarotti, P.; Marinone, C.; Pagano, M.; Rossi, G.; de Crescenzo, A.; Salomone, A.; Ladetto, M.; Boccadoro, M.; Pileri, A. 2001: High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments. Annals of Hematology 80(Suppl 3): B123-B126

Sanna, P.; Van den Bosch, S.; Cavalli, F.; Ghielmini, M. 1998: High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma. Schweizerische Medizinische Wochenschrift 128(40): 1500-1507

Lüftjohann, D.; Sigit, J.I.; Locatelli, S.; von Bergmann, K.; Schmidt, H.H. 2001: High-dose simvastin (80 mg/day) decreases plasma concentrations of total homocyst(e)ine in patients with hypercholesteromia. Atherosclerosis 155(1): 265-266

Asada, Y.; Suzuki, H.; Nakabayashi, S.; Furukawa, M. 1998: High-dose steroid therapy for sudden deafness--efficacy in severe cases. Nihon Jibiinkoka Gakkai Kaiho 101(9): 1069-1074

Ellis, M.F. 1993: High-dose steroid therapy offers improvement in spinal cord injuries. AACN Clinical Issues in Critical Care Nursing 4(3): 566-572

Theiss, W.; Busch, U.; Renner, U.; Blömer, H. 1996: High-dose streptokinase therapy with three million units in one hour significantly improves early coronary patency rates in acute myocardial infarction. American Journal of Cardiology 78(10): 1167-1169

Commissaris, R.L.; Hill, T.J. 1994: High-dose subchronic imipramine treatment: effects on anxiety-like (conflict) behavior in rats. Anxiety 1(3): 109-113

Martinez, A.E.; Atherton, D.J. 2000: High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatric Dermatology 17(2): 87-90

Sakuma, Y.; Uchida, H.; Nagai, H.; Kobayashi, E. 2001: High-dose tacrolimus and lengthy survival of the combined rat pancreas/spleen graft in a high-responder combination. Transplant Immunology 9(1): 37-42

Armitage 2001: High-dose therapy and ABMT for follicular lymphoma. Blood 97(2): 337-338

Fleury, J.; Legros, M.; Colombat, P.; Cure, H.; Travade, P.; Tortochaux, J.; Dionet, C.; Chollet, P.; Linassier, C.; Lamagnere, J.P.; Blaise, D.; Viens, P.; Maraninchi, D.; Plagne, R. 1996: High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease. Leukemia and Lymphoma 20(3-4): 259-266

Frankovich, J.; Donaldson, S.S.; Lee, Y.; Wong, R.M.; Amylon, M.; Verneris, M.R. 2001: High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 7(1): 49-57

Cao, T.M.; Horning, S.; Negrin, R.S.; Hu, W.W.; Johnston, L.J.; Taylor, T.L.; Shizuru, J.A.; Hoppe, R.T.; Brown, B.W.; Blume, K.G.; Stockerl-Goldstein, K.E. 2001: High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 7(5): 294-301

Sweetenham, J.W.; Carella, A.M.; Taghipour, G.; Cunningham, D.; Marcus, R.; Della Volpe, A.; Linch, D.C.; Schmitz, N.; Goldstone, A.H. 1999: High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(10): 3101-3109

Dowling, A.J.; Prince, H.M.; Wirth, A.; Wolf, M.; Januszewicz, E.H.; Juneja, S.; Seymour, J.F.; Gates, P.; Smith, J.G. 2001: High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience. Internal Medicine Journal 31(5): 279-289

Majolino, I.; Marcenò, R.; Pecoraro, G.; Scimé, R.; Vasta, S.; Liberti, G.; Rizzo, A.; Indovina, A.; Caronia, F. 1993: High-dose therapy and autologous transplantation in amyloidosis-AL. Haematologica 78(1): 68-71

Lotz, J.P.; Pene, F.; Bouleuc, C.; André, T.; Gligorov, J.; Avenin, D.; Esteso, A.; Bellaiche, A.; Macovei, C.; Merad, Z.; Laadem, A.; Vanica, R.; Izrael, V. 1996: High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors. Contraception Fertilite Sexualite 24(4): 307-318

Barlogie, B.; Shaughnessy, J.; Zangari, M.; Tricot, G. 2002: High-dose therapy and immunomodulatory drugs in multiple myeloma. Seminars in Oncology 29(6 Suppl 17: 26-33

Kitajima, H.; Nasu, K.; Tsudo, M.; Fujimoto, M.; Hayashi, K.; Ohno, H.; Konaka, Y.; Katsurada, T.; Arima, N.; Doi, S.; Moriguchi, T.; Fukuhara, S. 2001: High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study. Japanese Journal of Clinical Hematology 42(3): 191-198

Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial. Leukemia 10 Suppl. 2: S69-S71

Koh, L.P.; Linn, Y.C.; Teoh, G.; Goh, Y.T.; Tan, P.H.C. 2002: High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma. Annals of the Academy of Medicine Singapore 31(6): 731-737

Haioun, C.; Lepage, E.; Gisselbrecht, C.; Coiffier, B.; Doyen, C.; Morel, P.; Attal, M.; Tilly, H.; Deconinck, E.; Gaulard, P.; Reyes, F. 1998: High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(Suppl 1): S5-S8

Linch, D.C.; Goldstone, A.H. 1999: High-dose therapy for Hodgkin's disease. British Journal of Haematology 107(4): 685-690

Pettengell, R. 1996: High-dose therapy for aggressive non-Hodgkin's lymphoma. British Journal of Hospital Medicine 56(10): 521-524

Perry, A.R.; Goldstone, A.H. 1998: High-dose therapy for diffuse large-cell lymphoma in first remission. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(Suppl 1): S9-14

Freedman, A.; Friedberg, J.W.; Gribben, J. 2000: High-dose therapy for follicular lymphoma. Oncology 14(3): 321-326; 329; Discussion: 330-332, 338

Anderson-Reitz, L.; Mechling, B.E.; Hertz, S.L. 1999: High-dose therapy for treatment of breast cancer. Nurse Practitioner Forum 10(3): 154-158

Carlo-Stella, C.; Mangoni, L.; Caramatti, C.; Almici, C.; Rizzoli, V. 1997: High-dose therapy in acute leukemia. Leukemia and Lymphoma 26(Suppl 1): 61-67

Caballero, M.D.; Pérez-Simón, J.A.; Iriondo, A.; Lahuerta, J.J.; Sierra, J.; Marín, J.; Gandarillas, M.; Arranz, R.; Zuazu, J.; Rubio, V.; Fernández de Sevilla, A.; Carreras, E.; García-Conde, J.; García-Laraña, J.; Grande, C.; Sureda, A.; Vidal, M.J.; Rifón, J.; Pérez-Equiza, C.; Varela, R.; Moraleda, J.M.; García Ruíz, J.C.; Albó, C.; Cabrera, R.; San Miguel, J.F.; Conde, E. 2003: High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 14(1): 140-151

Mink, S.A.; Armitage, J.O. 2001: High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma. Oncologist 6(3): 247-256

Samson, D. 1996: High-dose therapy in multiple myeloma. Current Opinion in Hematology 3(6): 446-452

Patriarca, F.; Damiani, D.; Fanin, R.; Grimaz, S.; Geromin, A.; Cerno, M.; Sperotto, A.; Silvestri, F.; Zaja, F.; Baccarani, M. 2000: High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome. Haematologica 85(3): 269-274

Kvalheim, G.; Pharo, A.; Holte, H.; Jakobsen, E.; Erikstein, B.; Kvaløy, S.; Beiske, K.; Nesland, J.M.; Smeland, E.B. 1996: High-dose therapy of cancer with CD34 positive cells as stem cell support. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(21): 2542-2546

Mareschová, I. 1997: High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W". Vnitrni Lekarstvi 43(5): 345

Tempero, M.; Leichner, P.; Baranowska-Kortylewicz, J.; Harrison, K.; Augustine, S.; Schlom, J.; Anderson, J.; Wisecarver, J.; Colcher, D. 2000: High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase i trial. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(8): 3095-3102

Foran, J.M.; Apostolidis, J.; Papamichael, D.; Norton, A.J.; Matthews, J.; Amess, J.A.; Lister, T.A.; Rohatiner, A.Z. 1998: High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(8): 865-869

Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J. 1994: High-dose therapy with autologous stem cell support in malignant diseases. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115

Kolstad, A.; Holte, H.; Kvaløy, S.; Jakobsen, E.; Erikstein, B.; Aurlien, E.; Kvalheim, G.; Bøhler, P.J.; Langholm, R. 1996: High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(21): 2547-2551

Brice, P.; Simon, D.; Bouabdallah, R.; Bélanger, C.; Haïoun, C.; Thieblemont, C.; Tilly, H.; Harousseau, J.L.; Doyen, C.; Martin, C.; Brousse, N.; Solal-Céligny, P.H. 2000: High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(12): 1585-1590

Verdonck, L.F. 1999: High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(9): 3003

Matheson, I. 1996: High-dose therapy with cytostatic agents as primary treatment of advanced breast cancer. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(16): 1904-1906

Duswald, K.H.; Penk, A.; Pittrow, L. 1997: High-dose therapy with fluconazole > or = 800 mg day-1. Mycoses 40(7-8): 267-277

Penk, A.; Pittrow, L. 1997: High-dose therapy with fluconazole > or = 800 mg/day. Review. Mycoses 40(Suppl 1): 33-42

Alvarnas, J.C.; Negrin, R.S.; Horning, S.J.; Hu, W.W.; Long, G.D.; Schriber, J.R.; Stockerl-Goldstein, K.; Tierney, K.; Wong, R.; Blume, K.G.; Chao, N.J. 2000: High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 6(3a): 352-358

Tempero, M.; Leichner, P.; Dalrymple, G.; Harrison, K.; Augustine, S.; Schlam, J.; Anderson, J.; Wisecarver, J.; Colcher, D. 1997: High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase i trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(4): 1518-1528

Goldschmidt, H.; Hegenbart, U.; Wallmeier, M.; Hohaus, S.; Engenhart, R.; Wannenmacher, M.; Haas, R. 1997: High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(3): 243-246

Müngersdorf, M.; Sommer, U.; Sommer, M.; Reichmann, H. 2001: High-dose therapy with ropinirole in patients with Parkinson's disease. Journal of Neural Transmission 108(11): 1309-1317

Chen, A.R. 1999: High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results. Pediatric Transplantation 3(Suppl 1): 78-86

Nylenna, M.; Haug, C.; Bjørndal, A. 1996: High-dose therapy with stem cell support and support by a cabinet minister. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(21): 2537-2539

Winter, J.N. 1999: High-dose therapy with stem-cell transplantation in the malignant lymphomas. Oncology 13(12): 1635-1645; Discussion: 1645-1650; 1653-1654

Canellos, G.P. 1994: High-dose therapy: here to stay or just visiting?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(1): 5-6

Bengala, C.; Pazzagli, I.; Innocenti, F.; Donati, S.; Favre, C.; Menconi, M.C.; Greco, F.; Danesi, R.; Orlandini, C.; Guarneri, V.; Del Tacca, M.; Conte, P.F. 2001: High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC). Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(1): 69-74

Izhogin, D.G.; Boiarshinov, V.K.; Dolgonolov, I.S.; Iankelevich, M.I.; Ptushkina, E.A.; Mentkevich, G.L. 2000: High-dose thiotepa chemotherapy in children. Voprosy Onkologii 46(4): 401-406

Haley, E.C. 1998: High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS Ii Investigators. Stroke 29(6): 1256-1257

Rowinsky, E.K.; Baker, S.D.; Burks, K.; O'Reilly, S.; Donehower, R.C.; Grochow, L.B. 1998: High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase Ii and pharmacodynamic study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(2): 173-180

Gershanovich, M.; Hayes, D.F.; Ellmén, J.; Vuorinen, J. 1997: High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer. Oncology 11(5 Suppl 4: 29-36

Grond, S.; Radbruch, L.; Meuser, T.; Loick, G.; Sabatowski, R.; Lehmann, K.A. 1999: High-dose tramadol in comparison to low-dose morphine for cancer pain relief. Journal of Pain and Symptom Management 18(3): 174-179

Cizza, G.; Gold, P.W.; Chrousos, G.P. 1997: High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression. Journal of Clinical Endocrinology and Metabolism 82(2): 704

Rohatiner, A.Z.; Bassan, R.; Raimondi, R.; Amess, J.A.; Arnott, S.; Personen, A.; Rodeghiero, F.; Barbui, T.; Bradburn, M.J.; Carter, M.; Lister, T.A. 2000: High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(8): 1007-1015

Rohatiner, A.Z.S. 2002: High-dose treatment with autologous haemopoietic progenitor cell support for large B-cell, follicular and mantle-cell lymphoma. Best Practice and Research. Clinical Haematology 15(3): 467-480

Siegert, W.; Beyer, J.; Strohscheer, I.; Baurmann, H.; Oettle, H.; Zingsem, J.; Zimmermann, R.; Bokemeyer, C.; Schmoll, H.J.; Huhn, D. 1994: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/Ii study. the German Testicular Cancer Cooperative Study Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(6): 1223-1231

Eriksson, B.; Renstrup, J.; Imam, H.; Oberg, K. 1997: High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(10): 1041-1044

Hum, M.; Holcenberg, J.S.; Tkaczewski, I.; Weaver, J.W.; Wilson, J.; Kamen, B.A. 1998: High-dose trimetrexate and minimal-dose leucovorin: a case for selective protection?. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(12): 2981-2984

Krutmann, J. 1997: High-dose ultraviolet A1 (UVA1) phototherapy: does it work?. Photodermatology Photoimmunology and Photomedicine 13(3): 78-81

Giacoia, G.P. 1993: High-dose urokinase therapy in newborn infants with major vessel thrombosis. Clinical Pediatrics 32(4): 231-237

Harnois, D.M.; Angulo, P.; Jorgensen, R.A.; Larusso, N.F.; Lindor, K.D. 2001: High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. American Journal of Gastroenterology 96(5): 1558-1562

Anonymous 1998: High-dose valaciclovir linked to problems. TreatmentUpdate 10(1): 4-6

Di Filippo, A.; Grechi, S.; Rizzo, L.; Benvenuti, S.; Novelli, G.P. 1995: High-dose vecuronium in "open-eye" emergency surgery. Minerva Anestesiologica 61(11): 457-462

Gokel, Y.; Paydas, S.; Duru, M. 2000: High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure. American Journal of Emergency Medicine 18(6): 738-739

Beyer, J.; Stenning, S.; Gerl, A.; Fossa, S.; Siegert, W. 2002: High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis. Annals of oncology: official journal of the European Society for Medical Oncology 13(4): 599-605

Hiddemann, W.; Aul, C.; Maschmeyer, G.; Schönrock-Nabulsi, R.; Ludwig, W.D.; Bartholomäus, A.; Bettelheim, P.; Becker, K.; Balleisen, L.; Lathan, B. 1993: High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison. Leukemia and Lymphoma 10 Suppl: 133-137

Tzaneva, S.; Seeber, A.; Schwaiger, M.; Hönigsmann, H.; Tanew, A. 2001: High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. Journal of the American Academy of Dermatology 45(4): 503-507

Berry, D.A.; Broadwater, G.; Klein, J.P.; Antman, K.; Aisner, J.; Bitran, J.; Costanza, M.; Freytes, C.O.; Stadtmauer, E.; Gale, R.P.; Henderson, I.C.; Lazarus, H.M.; McCarthy, P.L.; Norton, L.; Parnes, H.; Pecora, A.; Perry, M.C.; Rowlings, P.; Spitzer, G.; Horowitz, M.M. 2002: High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(3): 743-750

Branch, D.R. 1999: High-dose vitamin C supplementation increases plasma glucose. Diabetes Care 22(7): 1218-1219

Graphakos, S.; Goussetis, E.; Peristeri, J.; Kitra, V.; Papadakis, V.; Aroni, S. 1996: High-dose, continuous r-TPA infusion for treatment of VOD. Bone Marrow Transplantation 18(5): 1026-1028

Leborgne, F.; Leborgne, J.H.; Zubizarreta, E.; Fowler, J.F.; Maisonneuve, J.; Ferrari, D.; Curochquin, R. 2001: High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 11(6): 445-453

Micheletti, E.; La Face, B.; Feroldi, P.; Galelli, M.; Buttolo, L.; Stefini, R.; Giunta, F. 1996: High-dose-rate brachytherapy for poor-prognosis, high-grade glioma: (phase II) preliminary results. Tumori 82(4): 339-344

Rudoltz, M.S.; Perkins, R.S.; Luthmann, R.W.; Fracke, T.D.; Green, T.M.; Moye, L.; Wludyka, P.; Choi, Y.K.; Ackerman, S.N. 1999: High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. Laryngoscope 109(12): 1967-1973

Tyree, W.C.; Cardenes, H.; Randall, M.; Papiez, L. 2002: High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 12(1): 27-31

Gava, A.; Fontan, L.; Bolner, A.; Botturi, M.; Cafaro, I.; Di Marco, A.; Marazzato, G.; Muto, P.; Orecchia, R.; Orsatti, M.; Parisi, S.S.; Rigon, A. 1996: High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience. La Radiologia Medica 91(1-2): 118-121

MacLeod, C.; Fowler, A.; Dalrymple, C.; D'Costa, I.; Firth, I.; Atkinson, K.; Elliot, P.; Carter, J. 1997: High-dose-rate brachytherapy in the management of carcinoma of the cervix: an 8-year Australian experience. Australian and New Zealand Journal of Obstetrics and Gynaecology 37(3): 342-347

Syed, A.M.; Puthawala, A.; Sharma, A.; Gamie, S.; Londrc, A.; Cherlow, J.M.; Damore, S.J.; Nazmy, N.; Sheikh, K.M.; Ko, S.J. 2001: High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control: Journal of the Moffitt Cancer Center 8(6): 511-521

Glatzel, M.; Büntzel, J.; Schröder, D.; Küttner, K.; Fröhlich, D. 2002: High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Laryngoscope 112(8 Part 1): 1366-1371

Orecchia, R.; Ragona, R.; Anglesio, S.; Tessa, M.; Del Mastro, E.; Sannazzari, G.L. 1996: High-dose-rate brachytherapy. The indications, technic and preliminary results. Minerva Medica 87(1-2): 1-7

Solomonov, A.; Rosenblatt, E.; Ben-Izhak, O.; Goralnik, L.; Yigla, M. 2001: High-dose-rate endobronchial brachytherapy in endobronchial metastatic malignant chondroid syringoma. Respiration; International Review of Thoracic Diseases 68(4): 406-410

Hu, K.S.; Enker, W.E.; Harrison, L.B. 2002: High-dose-rate intraoperative irradiation: current status and future directions. Seminars in Radiation Oncology 12(1): 62-80

Cengiz, M.; Ozyar, E.; Ersu, B.; Akyol, F.H.; Atahan, I.L. 1999: High-dose-rate mold brachytherapy of early gingival carcinoma: a clinical report. Journal of Prosthetic Dentistry 82(5): 512-514

Lu, J.J.; Bains, Y.S.; Abdel-Wahab, M.; Brandon, A.H.; Wolfson, A.H.; Raub, W.A.; Wilkinson, C.M.; Markoe, A.M. 2002: High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma. Cancer Journal 8(1): 74-78

Petereit, D.G.; Sarkaria, J.N.; Potter, D.M.; Schink, J.C. 1999: High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. International Journal of Radiation Oncology Biology Physics 45(5): 1267-1274

Bosch, T.; Lennertz, A.; Samtleben, W. 2001: High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report. Therapeutic Apheresis: Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis 5(5): 358-363

Li, M.; Xu, H.; Chen, C.-Q. 2000: High-efficiency Expression of Prolyl Endopeptidase from Aeromonas punctata subsp. Punctata in Escherichia coli. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica et Biophysica Sinica 32(2): 183-186

Bielefeldt-Ohmann, H.; Fitzpatrick, D.R. 1997: High-efficiency T-vector cloning of PCR products by forced a tagging and post-ligation restriction enzyme digestion. Biotechniques 23(5): 822

Afonin, A.G.; Baranov, V.T.; Biryukov, V.M.; Breese, M.B.; Chepegin, V.N.; Chesnokov, Y.A.; Guidi, V.; Ivanov, Y.M.; Kotov, V.I.; Martinelli, G.; Scandale, W.; Stefancich, M.; Terekhov, V.I.; Trbojevic, D.; Troyanov, E.F.; Vincenzi, D. 2001: High-efficiency beam extraction and collimation using channeling in very short bent crystals. Physical Review Letters 87(9): 094802

Schächter 1995: High-efficiency beam-wave interaction in quasiperiodic structures. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 52(2): 2037-2044

Shiono, T.; Hamamoto, T.; Takahara, K. 2002: High-efficiency blazed diffractive optical elements for the violet wavelength fabricated by electron-beam lithography. Applied Optics 41(13): 2390-2393

Shen, Y.; Berger, S.J.; Anderson, G.A.; Smith, R.D. 2000: High-efficiency capillary isoelectric focusing of peptides. Analytical Chemistry 72(9): 2154-2159

Seki, M.; Carninci, P.; Nishiyama, Y.; Hayashizaki, Y.; Shinozaki, K. 1998: High-efficiency cloning of Arabidopsis full-length cDNA by biotinylated CAP trapper. Plant Journal: for Cell and Molecular Biology 15(5): 707-720

Seidel; Titkov; André; Voisin; Voos 1994: High-efficiency energy up-conversion by an "Auger fountain" at an InP-AlInAs type-Ii heterojunction. Physical Review Letters 73(17): 2356-2359

Orzechowski; Anderson; Clark; Fawley; Paul; Prosnitz; Scharlemann; Yarema; Hopkins; Sessler; Wurtele 1986: High-efficiency extraction of microwave radiation from a tapered-wiggler free-electron laser. Physical Review Letters 57(17): 2172-2175

Ivanchenko 1996: High-efficiency frequency generation in a periodic array of Josephson junctions. Physical Review. B Condensed Matter 54(18): 13247-13260

Horwood, N.J.; Smith, C.; Andreakos, E.; Quattrocchi, E.; Brennan, F.M.; Feldmann, M.; Foxwell, B.M.J. 2002: High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. Arthritis Research 4(Suppl 3): S215-S225

Zhou, P.; Lee, J.; Moore, P.; Brasky, K.M. 2001: High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression. Human Gene Therapy 12(15): 1843-1855

Bayle, J.Y.; Johnson, L.G.; St George, J.A.; Boucher, R.C.; Olsen, J.C. 1993: High-efficiency gene transfer to primary monkey airway epithelial cells with retrovirus vectors using the gibbon ape leukemia virus receptor. Human Gene Therapy 4(2): 161-170

Brooks, B.; Phillips, R.S.; Benisek, W.F. 1998: High-efficiency incorporation in vivo of tyrosine analogues with altered hydroxyl acidity in place of the catalytic tyrosine-14 of Delta 5-3-ketosteroid isomerase of Comamonas (Pseudomonas) testosteroni: effects of the modifications on isomerase kinetics. Biochemistry 37(27): 9738-9742

Cho, H.J.; Farrand, S.K.; Noel, G.R.; Widholm, J.M. 2000: High-efficiency induction of soybean hairy roots and propagation of the soybean cyst nematode. Planta 210(2): 195-204

Shen, Y.; Zhao, R.; Berger, S.J.; Anderson, G.A.; Rodriguez, N.; Smith, R.D. 2002: High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Analytical Chemistry 74(16): 4235-4249

Goomer, R.S.; Deftos, L.J.; Terkeltaub, R.; Maris, T.; Lee, M.C.; Harwood, F.L.; Amiel, D. 2001: High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects. Osteoarthritis and Cartilage 9(3): 248-256

Zhang, Y.; Zhu, J.; Zhang, L.; Zhang, W. 2000: High-efficiency on-line concentration technique of capillary electrochromatography. Analytical Chemistry 72(22): 5744-5747

Moerner; Schellenberg; Bjorklund; Kaipa; Lüty 1985: High-efficiency photochemical hole burning for an infrared color center. Physical Review. B Condensed Matter 32(2): 1270-1277

Lautanen, J.; Kettunen, V.; Lakkonen, P.; Turunen, J. 2000: High-efficiency production of propagation-invariant spot arrays. Journal of the Optical Society of America. a Optics Image Science and Vision 17(12): 2208-2215

Chen, X.; Liao, J.-L.; Liang, Y.; Ahmed, M.O.; Tseng, H.-E.; Chen, S.-A. 2003: High-efficiency red-light emission from polyfluorenes grafted with cyclometalated iridium complexes and charge transport moiety. Journal of the American Chemical Society 125(3): 636-637

Li, Z.X.; Schade, U.M.; Fehse, B.; Stockschläder, M.; Uhde, A.; Koch, S.; Goller, B.; Rüger, R.; Fehse, N.; Zander, A.R. 1998: High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes. Advances in Experimental Medicine and Biology 451: 375-378

Ginzburg; Kaminsky; Kaminsky; Peskov; Sedykh; Sergeev; Sergeev 2000: High-efficiency single-mode free-electron maser oscillator based on a bragg resonator with step of phase of corrugation. Physical Review Letters 84(16): 3574-3577

Kwiat; Steinberg; Chiao; Eberhard; Petroff 1993: High-efficiency single-photon detectors. Physical Review. A Atomic Molecular and Optical Physics 48(2): R867-R870

Zeng, M.; Cerniglia, G.J.; Eck, S.L.; Stevens, C.W. 1997: High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Human Gene Therapy 8(9): 1025-1032

Jørgensen, F.; Hansen, O.C.; Stougaard, P. 2001: High-efficiency synthesis of oligosaccharides with a truncated beta-galactosidase from Bifidobacterium bifidum. Applied Microbiology and Biotechnology 57(5-6): 647-652

Leimig, T.; Brenner, M.; Ramsey, J.; Vanin, E.; Blaese, M.; Dilloo, D. 1996: High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors. Human Gene Therapy 7(10): 1233-1239

Chiorini, J.A.; Wendtner, C.M.; Urcelay, E.; Safer, B.; Hallek, M.; Kotin, R.M. 1995: High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Human Gene Therapy 6(12): 1531-1541

Woods, R.A.; Gietz, R.D. 2001: High-efficiency transformation of plasmid DNA into yeast. Methods in Molecular Biology 177: 85-97

Kwan 1986: High-efficiency, magnetized, virtual-cathode microwave generator. Physical Review Letters 57(15): 1895-1898

Iguchi 1993: High-electric-field behavior of the magnetophonon resonance in polar semiconductors. Physical Review. B Condensed Matter 47(12): 7049-7060

Nebel; Street; Johnson; Kocka 1992: High-electric-field transport in a-Si:H. I. Transient photoconductivity. Physical Review. B Condensed Matter 46(11): 6789-6802

Nebel; Street; Johnson; Tsai 1992: High-electric-field transport in a-Si:H. II. Dark conductivity. Physical Review. B Condensed Matter 46(11): 6803-6814

Patton, J.A.; Sandler, M.P.; Ohana, I.; Weinfeld, Z. 1996: High-energy (511-keV) imaging with the scintillation camera. Radiographics: a Review Publication of the Radiological Society of North America Inc 16(5): 1183-1194

White, S.N.; Yu, Z.; Zhao, X.Y. 1994: High-energy abrasion: an innovative esthetic modality to enhance adhesion. Journal of Esthetic Dentistry 6(6): 267-273

Mattis; McLerran; Yaffe 1992: High-energy anomalous scattering: Is it semiclassical?. Physical Review. D Particles and Fields 45(11): 4294-4302

Yin; Gabriel; Pratt 1987: High-energy atomic photoelectric effect and bremsstrahlung. Physical Review. A General Physics 36(3): 1207-1219

Clark, N.; Birely, B.; Manson, P.N.; Slezak, S.; Kolk, C.V.; Robertson, B.; Crawley, W. 1996: High-energy ballistic and avulsive facial injuries: classification, patterns, and an algorithm for primary reconstruction. Plastic and Reconstructive Surgery 98(4): 583-601

Robertson, B.C.; Manson, P.N. 1999: High-energy ballistic and avulsive injuries. a management protocol for the next millennium. Surgical Clinics of North America 79(6): 1489-1502 Xi

Newberger; Tajima 1989: High-energy beam transport in crystal channels. Physical Review. A General Physics 40(12): 6897-6903

Fowler; Friedlander; Weiner; Wilk 1986: High-energy behavior of multiparticle distributions and their bounds. Physical Review Letters 56(1): 14-17

Levin; Sellin; Johnson; Lindle; Miller; Berrah; Azuma; Berry; Lee 1993: High-energy behavior of the double photoionization of helium from 2 to 12 keV. Physical Review. A Atomic Molecular and Optical Physics 47(1): R16-R19

White, S.L.; Harpaz, N.T.; Jolly, G.P.; Gorecki, G.A. 1999: High-energy bilateral talar neck fractures secondary to motocross injury. Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 38(3): 214-218

Raineri; Setola; Priolo; Rimini; Galvagno 1991: High-energy channeling implants of phosphorus along the silicon. Physical Review. B Condensed Matter 44(19): 10568-10577

Arakawa, R.; Kobayashi, M.; Nishimura, T. 2000: High-energy collision-induced dissociation of small polycyclic aromatic hydrocarbons. Journal of Mass Spectrometry: Jms 35(2): 178-182

Harvey, D.J.; Bateman, R.H.; Green, M.R. 1997: High-energy collision-induced fragmentation of complex oligosaccharides ionized by matrix-assisted laser desorption/ionization mass spectrometry. Journal of Mass Spectrometry: Jms 32(2): 167-187

Gerbaux, P.; Sciamanna, V.; Flammang, R.; Nguyen, M.T. 2001: High-energy collisional activation of the molecular ions of thiophene-2-one with different target gases. Journal of Mass Spectrometry: Jms 36(1): 97-101

Minakata; Smirnov 1996: High-energy cosmic neutrinos and the equivalence principle. Physical Review. D Particles and Fields 54(6): 3698-3705

Lamm; Wiss; Avery; Butler; Gladding; Goodman; O'Halloran; Russell; Wattenberg; Busenitz; Callahan; Olszewski; Binkley; Cumalat; Gaines; Gormley; Peoples; Harding; Atiya; Hartouni; Holmes; Knapp; Lee; Seto; Wisniewski 1987: High-energy diffraction dissociation of KL0 into exclusive final states. Physical Review. D Particles and Fields 36(11): 3341-3352

Dahm, J.B.; Kuon, E. 2000: High-energy eccentric excimer laser angioplasty for debulking diffuse iIn-stent restenosis leads to better acute- and 6-month follow-up results. Journal of Invasive Cardiology 12(7): 335-342

Kundrát; Lokajícek; Krupa 1992: High-energy elastic hadron scattering in Coulomb and hadronic regions. Physical Review. D Particles and Fields 46(9): 4087-4090

Menard, C.M.; Bews, J.; Skoracki, R.I.; Chowdhury, A.D. 1999: High-energy electron and photon therapy to the parotid bed: radiation dose perturbations with a titanium mandibular implant. Australasian Radiology 43(4): 495-499

Giulietti, D.; Galimberti, M.; Giulietti, A.; Gizzi, L.A.; Borghesi, M.; Balcou, P.; Rousse, A.; Rousseau, J.P. 2001: High-energy electron beam production by femtosecond laser interactions with exploding-foil plasmas. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(1 Part 2): 015402

Zhang; Ross; Fink 1991: High-energy electron scattering study of molecular hydrogen. Physical Review. A Atomic Molecular and Optical Physics 43(7): 3548-3552

Zhengming; Brahme 1992: High-energy electron transport. Physical Review. B Condensed Matter 46(24): 15739-15752

Kielwein; Saiki; Roth; Fink; Paasch; Egdell 1995: High-energy electron-energy-loss study of sodium-tungsten bronzes. Physical Review. B Condensed Matter 51(16): 10320-10335

Casalbuoni; De Curtis S; Dominici; Feruglio; Gatto 1989: High-energy equivalence theorem in spontaneously broken supergravity. Physical Review. D Particles and Fields 39(8): 2281-2288

Rompe, J.D.; Rosendahl, T.; Schöllner, C.; Theis, C. 2001: High-energy extracorporeal shock wave treatment of nonunions. Clinical Orthopaedics and Related Research 387: 102-111

Vogel, J.; Rompe, J.D.; Hopf, C.; Heine, J.; Bürger, R. 1997: High-energy extracorporeal shock-wave therapy (ESWT) in the treatment of pseudarthrosis. Zeitschrift für Orthopadie und ihre Grenzgebiete 135(2): 145-149

Nesbet; Geltman 1986: High-energy forward elastic scattering of electrons: Partial-wave approximations. Physical Review. A General Physics 33(6): 3815-3824

Weigel, D.P.; Marsh, J.L. 2002: High-energy fractures of the tibial plateau. Knee function after longer follow-up. Journal of Bone and Joint Surgery. American Volume 84(9): 1541-1551

Gossett; Behr; Luke; McLain; Rosenzweig; Snover; Hering 1990: High-energy gamma emission in heavy-ion collisions at 9-14 MeV/nucleon. Physical Review. C Nuclear Physics 42(5): 1800-1804

Kerr, G. 1996: High-energy gamma rays at Hiroshima and Nagasaki. Health Physics 71(1): 94-95

Murakami; Benenson; Chen; Clayton; Kashy; Stevenson; Tam; Hanold; Mohar 1989: High-energy gamma rays from reactions induced by E/A=15 MeV heavy-ion beams. Physical Review. C Nuclear Physics 40(5): 2079-2083

Stevenson; Beard; Benenson; Clayton; Kashy; Lampis; Morrissey; Samuel; Smith; Tam; Winfield 1986: High-energy gamma-ray emission in heavy-ion collisions. Physical Review Letters 57(5): 555-558

Tam; Stevenson; Benenson; Clayton; Chen; Kashy; Lampis; Morrissey; Samuel; Murakami; Winfield 1988: High-energy gamma-ray production in light-ion induced reactions. Physical Review. C Nuclear Physics 38(6): 2526-2530

Clayton; Stevenson; Benenson; Chen; Kashy; Lampis; Samuel; Tam; Mohar; Morrissey; Murakami; Sherrill; Winfield 1989: High-energy gamma-ray production in the heavy-ion reaction 136Xe + Sn at E/A=89 and 124 MeV. Physical Review. C Nuclear Physics 40(3): 1207-1212

Vásconez, H.C.; Shockley, M.E.; Luce, E.A. 1996: High-energy gunshot wounds to the face. Annals of Plastic Surgery 36(1): 18-25

Ornik; Pottag; Weiner 1989: High-energy heavy-ion reactions and relativistic hydrodynamics in three dimensions. Physical Review Letters 63(24): 2641-2644

Kanca, J. 2001: High-energy illumination of the truth, or the serial endorser?. Journal of Esthetic and Restorative Dentistry: Official Publication of the American Academy of Esthetic Dentistry . 13(3): 147-149

Courant; Pellegrini; Zakowicz 1985: High-energy inverse free-electron-laser accelerator. Physical Review. A General Physics 32(5): 2813-2823

Smith; Hennessy; Kim; Whang; Worthington; Mingde 1987: High-energy ion-scattering studies of anisotropic surface-atom vibrations on W(110). Physical Review Letters 58(7): 702-705

Matiushichev, V.B.; Soldatov, A.I. 1994: High-energy laser irradiation in the combined treatment of duodenal ulcer. Klinicheskaia Meditsina 72(4): 15-16

Lapchenko, A.S. 2002: High-energy laser radiation in otorhinolaryngology: past and future. Vestnik Otorinolaringologii 3: 61-64

Teodorovich, O.V.; Mulabaev, S.K. 1997: High-energy laser technologies in the treatment of patients with benign prostatic hyperplasia. Urologiia i Nefrologiia 4: 41-46

Matiushichev, V.B.; Soldatov, A.I.; Linkevich, E.L. 1997: High-energy laser therapy of stomach ulcers. Klinicheskaia Meditsina 75(12): 41-44

Sandvik, A.W.; Singh, R.R. 2001: High-energy magnon dispersion and multimagnon continuum in the two-dimensional Heisenberg antiferromagnet. Physical Review Letters 86(3): 528-531

Cornwall; Tiktopoulos 1992: High-energy multileg electroweak processes and unitarity. Physical Review. D Particles and Fields 45(6): 2105-2120

Stecker; Done; Salamon; Sommers 1991: High-energy neutrinos from active galactic nuclei. Physical Review Letters 66(21): 2697-2700

Atoyan, A.; Dermer, C.D. 2001: High-energy neutrinos from photomeson processes in blazars. Physical Review Letters 87(22): 221102

D'Errico, F.; Agosteo, S.; Sannikov, A.V.; Silari, M. 2002: High-energy neutron dosimetry with superheated drop detectors. Radiation Protection Dosimetry 100(1-4): 529-532

Hwa; Wang 1990: High-energy nuclear collisions in the geometrical branching model. Physical Review. D Particles and Fields 42(5): 1459-1467

Frankfurt; Miller; Strikman 1992: High-energy nuclear quasielastic reactions: Decisive tests of nuclear-binding/pion models of the European Muon Collaboration effect. Physical Review Letters 68(1): 17-20

Durand; Pi 1988: High-energy nucleon-nucleus scattering and cosmic-ray cross sections. Physical Review. D Particles and Fields 38(1): 78-84

Loong; Vashishta; Kalia; Degani; Price; Jorgensen; Hinks; Dabrowski; Mitchell; Richards; Zheng 1989: High-energy oxygen phonon modes and superconductivity in Ba1-xKxBiO3: An inelastic-neutron-scattering experiment and molecular-dynamics simulation. Physical Review Letters 62(22): 2628-2631

Murani; Eccleston 1996: High-energy paramagnetic spectral response of CeNi2. Physical Review. B Condensed Matter 53(1): 48-51

Routt, M.L.C.; Nork, S.E.; Mills, W.J. 2002: High-energy pelvic ring disruptions. Orthopedic Clinics of North America 33(1): 59-72 Viii

Thevuthasan; Ynzunza; Tober; Fadley; Kaduwela; Van Hove MA 1993: High-energy photoelectron holography for an adsorbate test system: c(2 x 2)S on Ni(001). Physical Review Letters 70(5): 595-598

Honjo; Durand; Gandhi; Pi; Sarcevic 1993: High-energy photon-nucleon and photon-nucleus cross sections. Physical Review. D Particles and Fields 48(3): 1048-1060

Chakrabarty; Alam; Srivastava; Sinha; Raha 1992: High-energy photons from expanding quark-gluon plasma and hot hadronic matter. Physical Review. D Particles and Fields 46(9): 3802-3806

Kapusta; Lichard; Seibert 1991: High-energy photons from quark-gluon plasma versus hot hadronic gas. Physical Review. D Particles and Fields 44(9): 2774-2788

Nakayama 1989: High-energy photons in neutron-proton and proton-nucleus collisions. Physical Review. C Nuclear Physics 39(4): 1475-1487

Kallianpur 1986: High-energy photoproduction of W bosons. Physical Review. D Particles and Fields 34(11): 3343-3349

Collins; Ladinsky 1991: High-energy photoproduction of jets. Physical Review. D Particles and Fields 43(9): 2847-2855

Busenitz; Olszewski; Callahan; Gladding; Wattenberg; Binkley; Butler; Cumalat; Gaines; Gormley; Harding; Loveless; Peoples 1989: High-energy photoproduction of pi + pi - pi 0, K+K-, and pp-bar states. Physical Review. D Particles and Fields 40(1): 1-21

Seife, C. 2002: High-energy physics. Atom smasher probes realm of nuclear 'gas'. Science 295(5555): 603-604

Irion, R. 2001: High-energy physics. B-meson factories make a "number from hell". Science 291(5508): 1471

Seife, C. 2002: High-energy physics. CERN council chooses ITER's head as chief. Science 298(5602): 2309-2311

Weiss, G. 2002: High-energy physics. CERN panel calls for cuts and shake-ups. Science 296(5577): 2317

Weiss, G. 2002: High-energy physics. Cost overruns will hit research at CERN. Science 295(5564): 2341

Seife, C. 2001: High-energy physics. Muon experiment challenges reigning model of particles. Science 291(5506): 958